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ABSTRACT
A polymer nanostructured Fabry-Perot interferometer (FPI) based biosensor has
been developed, fabricated, and tested. Different from a conventional FPI, this
nanostructured FPI has a layer of Au-coated nanopores inside its cavity. The Au-coated
nanostructure layer offers significant enhancement of optical transducing signals due to
the localized surface Plasmon resonance (L-SPR) effect. Compared to a traditional FPI
for label-free biosensing applications, the polymer nanostructured FPI based biosensor
offers increased sensing surface area, extended penetration depth of the excitation light,
and

amplification of optical

transducing signals. Using a

nanostructured FPI,

measurements taken had great improvements in free spectral range (FSR), finesse, and
contrast of optical transducing signals over a traditional FPI without any device
performance optimization.
Several chemicals have been evaluated using the prototype device. Fourier
Transform has been performed on the measured optical signals to facilitate the analysis of
the transducing signals. Control experiments incubating immunoglobulin G (IgG) on a
gold surface confirmed the small affinity of IgG to the Au-coated sensing surface. Then,
using fluorescent images, shifts of interference fringes for IgG and BSA interaction were
indirectly confirmed.
Using this technical platform, the immobilization of capture proteins (Protein A)
on the nanostructure layer and their binding with IgG was monitored in real time,

iii

iv

resulting in the direct observation of the shift in interference fringes of the optical
transducing signals. The results showed that the detectionof limit (DOL) for this kind of
biosensor should be lower than 10 pg/mL, which is approximately 55 fM of IgG, for IgGProtein A binding. Control experiments were performed to confirm that the biodetection
is only specific to Protein A and IgG recognition.
After the proof-of-concept demonstration for IgG-Protein A binding, the
ultrasensitive label-free detection of a cancer biomarker free prostate specific antigen (fPSA) using this kind of nanostructured FPI was carried out. Experiments found that the
DOL of the fabricated nanostructured FPI microchip for f-PSA is about 5 pg/mL and the
upper detection range for f-PSA can be dynamically changed by varying the amount of
mAb immobilized on the sensing surface. Control experiments have also demonstrated
that the immunoassay protocol used shows excellent specificity and selectivity,
suggesting great potential to detect cancer biomarkers at trace levels in biofluids.
Given its nature of low cost, simple operation, and batch fabrication capability,
the nanostructured FPI microchip based platform could provide an ideal technical tool for
point-of-care diagnostic applications and anti-cancer drug screening and discovery.
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CHAPTER 1
INTRODUCTION
1.1

Overview of Biosensors

The human body is a perfect biosensing system. It can sense light, sound, smell,
taste and touch by means of eyes, ears, nose, tongue, and fingers,

respectively. For

thousands of years, people have tried to mimic the function of the human body, with
temperature sensors in refrigerators and airconditioners, gas sensors in gas-ovens,
infrared sensors in televisions, speed sensors in vehicles, and so on.
The first description of a biosensor was given by Leland C. Clark in 1962 as "a
device that transforms chemical information, ranging from the concentration of a specific
sample component to total composition analysis, into an analytically useful signal.
Chemical sensors usually contain two basic components connected in series: a chemical
(molecular) recognition system (receptor) and a physicochemical transducer. Biosensors
are chemical sensors in which the recognition system utilizes a biochemical mechanism"
[1], Thereafter, there has been an explosive growth of research on biosensors [2-5], which
have been used for a wide variety of applications such as environmental monitoring,
biomedical, and biological research.
According to the International Union of Pure and Applied Chemistry (IUPAC), a
biosensor is defined as a self-contained device, integrated with a biological recognition
element and a transducing element [6]. Since biosensors have evolved over the past five
1

2

decades, this definition is no longer appropriate. A more "modern" definition of
biosensor is given by Newman et al. as "a compact analytical device incorporating a
biological or biologically-derived sensing element either integrated within or intimately
associated with a physicochemical transducer" [7].
Abiosensor consists of analyte, bioreceptor, transducer, and signal detector [8].
The component of the biosensor is shown in Figure 1.1.
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Figure 1.1 Biosensor components [7],
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Analytes are chemical substances whose properties are measured for analytical
purposes. Receptors are responsible for immobilizing analytes on the surface of a
transducer. They include the antibody, enzyme, nucleic acid, etc. Antibodies are specific
to certain antigens. The interaction between an antibody and an antigen is just like the
relationship between a lock and a key. A specific antibody can only bind with a specific
antigen, and enzymes have specific binding capabilities. Enzymes are also well known
for their catalytic activities. In enzyme bioreceptor recognition, the detection is usually
enhanced by catalyzed reaction. By using an enzyme cascade, the catalyzed reaction can
be greatly amplified [9], Nucleic acid is another type of bioreceptor. During the past two
decades, with the emerging of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA),
which are the basis of genetics, scientists and researchers have shown more and more
interest in nucleic acids [10-15]. There are adenine : thymine (A : T) and cytosine :
guanine (C : G) pairs in DNA. They are the basis of the nucleic acid recognition.
Knowing one part of the pair, the other part can be synthesized which is usually identified
with labels such as fluorescent dyes. Transducers are components that transform signals
from one form to another that can be detected such as electrical, mechanical or optical
signals. Detectors are components that recover bio transducing signals and transform
them into electrical, mechanical or optical signals that can show information of interest
for analytical purposes.
Biomolecules are very small, weighted from less than 100 daltons to over 1,000
daltons. The typical size is from a few nanometers to a few microns, as shown in Figure

1.2.
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Figure 1.2 Scale sizes of biomolecules [10-15]

Transducing signals from biomolecules are very weak. In order to measure weak
signals from small biomolecules, devices with nano- or microscale are needed. To this
end, micro- and nanotechnologies have started to play a very important role in the
enhancement of the sensitivity and DOL of biosensing technologies. Representative
technologies include fluorescence [16], light scattering [17, 18], surface enhanced Raman
spectroscopy (SERS) [19], surface Plasmon resonance (SPR) [20], photonic crystal [21,
22], electrochemical immunosensing electrode [23], quartz crystal microbalance [24],
(micro-) nanocantilever [25, 26], nanowire [27, 28], carbon nanotube [29], nanoparticle
based localized SPR [30], nanohole and array [31], quantum dot [32, 33], magnetonanosensor [34], nanopore thin film [35, 36] technologies. Furthermore, recent technical
advancement in nanofabrication, nanomaterial synthesis, micro/nanofluidics and bioassay
has also enhanced the sensitivity or chip adaptability for the detection and quantification
of protein biomarkers in biological samples via the binding to antibodies or aptamers [37],
Biosensing can be realized by either the labeled or the label-free technique [3841]. The labeled biosensors require such labels as fluorescent dyes, radioisotopes, epitope
tags [42-44] to be attached to the analytes in order to identify whether or not there are
interactions. However, this technology has its own shortcomings such as the limited shelf

5

life of labels, the inherent toxicity caused by the labels which could also modify the
properties of biomolecules and the need for specific read-out instrumentswith intelligent
software and skilled lab personnel [8, 41 ].
In contrast to labeled biosensing, the label-free technique is attractive for
biosensing since no labels such as fluorescent dyes need to be attached to the
biomolecules. As a result, the experimental cost can be reduced dramatically, and the
possible perturbation of properties of biomolecules can be completely avoided. Labelfree biosensing is a very important and efficient technique for environmental monitoring,
biomedical, and biological research applications.

1.2

Label-Free Biosensors

There are three main categories of label-free biosensors in terms of transducing
mechanisms, as shown in Figure 1.3. These transducing mechanisms include electrical,
mechanical, and optical responses [27, 45, 46].

Electrical Transduction
Label free transduction
mechanism

Mechanical Transduction

Optical Transduction

Figure 1.3 Classification of label free biosensors.
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1.2.1

Electrical Label-Free
Biosensors
Electrical transduction is enabled by carbon nanotubes (CNTs) or nanowires

(NWs) where the electrical conductance of the CNTs or NWs changes upon the binding
between the receptors (antibodies-Abs) immobilized on them and the targets (antigensAgs). For example, the schematic of a NW based biosensor is shown in Figure 1.4.

NanoFET

Nanosensor

Figure 1.4 Schematic of a NW based biosensor [47],

The receptors (Abs) are first immobilized on NWs. Then, the targets (Ags) bind
with the receptors. The electrical conductance of the NWs changes upon the binding
between the receptors immobilized on them and the targets [27, 48, 49].
1.2.2

Mechanical Label-Free
Biosensors
Mechanical transduction is achieved by MEMS (Microelectromechanical systems)

or NEMS (Nanoelectromechanical systems) cantilevers where the binding between an

7

antigentic target and an antibody immobilized cantilever surface changes the surface
stress of the cantilever, resulting in its bending and the shifting of the resonant frequency.
For example, the schematic of a MEMS cantilever based biosensor is shown in Figure 1.5.
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Figure 1.5 Schematic of a MEMS cantilever based biosensor [50].

The receptors (Abs) are first immobilized on the tips of the MEMS cantilever.
Then, the targets (Ags) bind with the receptors. The binding between an antigentic target
and an antibody immobilized cantilever surface changes the surface stress of the
cantilever, resulting in its bending and the shifting of resonant frequency [50],
1.2.3

Optical Label-Free
Biosensors
Due to its non-invasive nature, high degree of sensitivity, capability of

multiplexing, and immunity to environmental noise, the optical technique is very
attractive for sensing applications. As nanotechnology has undergone explosive growth in

8

the past two decades, many optical components or systems such as lenses, gratings,
mirrors, microring resonators, and interferometers have, therefore, been miniaturized for
various sensing applications [51-56]. As a result, the field of microoptics and nanooptics
has emerged, triggering extensive research to scale down the optics-based sensing
platforms over the past decades. Optical label-free transduction can be achieved by such
techniques as propagating surface Plasmon resonance (PSPR) [57], Raman spectroscopy
[58], surface enhanced Raman spectroscopy (SERS) [59], localized SPR (L-SPR) [35],
liquid core optical ring resonator (LCORR) [60], photonic crystal (PC) nanostructures [58,
61], light scattering, quantum dots, microspheres [58], opto-fluidic ring resonators [59],
microring resonators [60], and thin film

interferometric devices [35, 36], These

technologies can provide exceptional sensitivity. Some of them can even offer DOL
down to the single molecular level, thus having great potential for the early stage
detection of cancer/disease biomarkers. Specifically, using these technologies, the
detection of a variety of disease biomarkers such as carcinoembryonic antigen (CEA) for
colon cancer, prostate-specific antigen (PSA) for prostate cancer, HER2 for breast cancer
and amyloid-beta derived diffusible ligands (ADDLs) for Alzheimer's disease has been
demonstrated and reported [59, 60].
Surface plasmons (SP) can beexcited on a metal and dielectric interface by a
monochromatic or nearmonochromatic optical source. Usually, a noble metal (gold,
silver or platinum) thin film (50-100 nm) is coated on the surface of the substrate such as
a glass slide or a prism, as shown in Figure 1.6.

9
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Figure 1.6 Schematic of a PSPR based label free biosensor [62].

The fields associated with the SP extend into the medium adjacent to the interface
and decay exponentially away from it. The penetration into the medium is in the range of
<100-200 nm. Consequently, the SP is very sensitive to changes in thickness or refractive
index in the environment near the interface between the metal and dielectric layers, and
therefore, is used as a sensing probe. Beyond this range, the biomolecules can hardly be
detected. Upon the excitation of the SPR, a valley in reflectance from the interface occurs.
The position of the valley shifts to a different angle of incidence given any changes in the
local environment at the interface.The SPR technique has seen tremendous growth over
the past decades and has been used for a variety of applications such as drug discovery
and homeland security [62],
Recently, LCORR technology has been demonstrated for multiplexed biosensing
by placing LCORR in contact with multiple anti-resonant reflecting optical waveguides
(ARROWs). It utilizes the ARROWs to excite the whispering gallery modes of a LCORR
sensor [63]. The schematic of a LCORR based label-free biosensor is shown in Figure 1.7.

10

Sample||
fluid

|

Target molecule

[~j

Laser

1

WGM

Figure 1.7 Schematic of a LCORR based label-free biosensor [63].

One type of photonic crystal (PC) biosensors consists of a silicon waveguide
adjacent to ID photonic crystal microcavity [64], which is evanescently coupled to each
other [21], A change in the refractive index of the near field region surrounding the
optical cavity results in a shift of the resonant wavelength, as shown in Figure 1.8.

Open sensing surface
TIR boundary
Defect layer
ID PC
X
Substrate
Prism

Figure 1.8 Schematic of a PC based label-free biosensor [64],

Microsphere biosensors utilize the whispering gallery modes (WGMs) technique
for the detection and analysis of microorganisms. The recirculation of photons in the
cavities of the microsphere can tremendously enhance the signal of the evanescent wave
between the microsphere and the surrounding medium. The enhancement of the
evanescent field can be exploited for ultrasensitive biodetection [58], Using microsphere
technology, label-free biodetection can be achieved by measuring the shift of resonance
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frequency before and after the biosample is immobilized on the surface of the
microsphere. However, specific detections of biomaterials need treatment or modification
of the mircrosphere cavity surface.
Porous silicon and alumina thin film

interferometry for label-free DNA and

protein interaction biodetection were pioneered by Sailor and co-workers [35, 65], yet
engineering efforts are still needed for nanopore thin film sensors to achieve
microfluidics-based multiplexed biosensing. A very important example of interferometric
device is Fabry-Perot interferometer (FPI). FPIs have been designed, micromachined, and
implemented for chemical sensing, gas sensing, ultrasonic sensing, and as optical
modulators [51, 52], As a chemical and gas sensor, the FP cavity serves as a sensing area.
The output signals reflect or transmit intensity through FPI, which changes with different
chemicals [51, 52], For ultrasonic sensing, the micromachined capacitive acoustic
transducer consists of an FPI cavity with embedded optical diffraction gratings on a
transparent substrate. The detection sensitivity can be maintained at an optimum level by
deflecting the membrane of the FPI. For optical modulation, an FPI contains a crosslinked electro-optic polymer inside its cavity, offering the potential for high timebandwidth modulation.
Various MEMS actuation mechanisms make some unique features of a

jj,FPI

possible. For instance, tunable (iFPIs have been demonstrated with electrostatic and
thermal actuators. They have been exploited and utilized for wavelength division
multiplexing (WDM) in optical communications [53] and Raman spectroscopy [54],
oxygen detection in blood sample [55], and spectral endoscope optical imaging [56]. For
WDM application, tunable JIFPI serves as a tunable filter, selecting different wavelengths
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by changing the gap size of the FPI cavity. For oxygen detection in blood samples, the
proposed jj .FPI device can detect a wide range of wavelength from visible to near infrared
light, offering sufficient characteristics to analyze the spectrum of the blood [55], For
spectral endoscope optical imaging, the device can acquire spectral images of a target at
each pixel [56], Recently, jxFPI has been used to study nanoscale fluid dynamics,
indicating its potential for nanoscience and nanotechnology research.
Usually, (aFPIs are fabricated from silicon, polysilicon, silicon nitride, silicon
oxide thin film or other semiconductor materials and are often operated by a laser source.
In order to further simplify the operational procedure and lower the cost, recently a
white-light source operated polymer FPI has been developed for (bio-) chemical sensing
by our group.
A FPI sensor is usually based on the principle of multiplebeam interference. In
order to show the basic principle of a FPI sensor, a simplified FPI sensor is demonstrated.
The refractive index inside an FPI sensor is related to its density, composition, pressure
and temperature. The structure of a conventional FPI sensor is shown in Figure 1.9.

1

4I

Figure 1.9 Structure of a conventional FPI sensor.

I is the input light, R x , R 2 , A are reflected light and E ] ,E 2 ,E i , A are transmitted
light. Optical fibers are used to collect reflected light into a spectrometer and the cavity is
formed by two metal coated mirrors. However, this structure results in high coupling loss
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when reflected light is coupled into optical fibers and low resolution [66]. The metal
coated mirror on one end is usually used as the input end of light and the other coated
mirror as the feedback mirror. In order to introduce the model, basic theories and
methods must be described. One must consider two parallel transparent plates of
refractive index n/, surrounded by a medium of refractive index «2, and suppose that a
plane wave of monochromatic light shines on the plate at incident angle 0 . The
corresponding phase difference is
471
8 = —n x hcos 9 ,
A.

(1-1)

where h is the thickness of the plate and X is the wavelength in vacuum. Let E 0 be the
amplitude of the electric vector of the incident wave, complex amplitudes of the waves
reflected from the plate are rE 0 , tt'r'E^e , u'r'^E^e1'* , A , tt'r nl '" 1) E 0 e' {p ~^ s , A , where
r is the reflection coefficient, t is the transmission coefficient for a wave incident from the
surrounding medium toward the plate, and r and /' are the corresponding quantities for
waves traveling from the plate toward surrounding medium [66, 67], The ratio of
reflected light intensity to incident light intensity is
4r 2 sin 2 —
?

R=

(1 —

r2)2

+4r 2

(

sin 2

1

-

2

)

—
2

Finesse is a key parameter of FPI. It is defined as the distance between the
interference peaks AA, divided by the full width half maximum (FWHM) 8A of the
peaks. Conceptually, finesse can be thought of as the number of interfering beams within
the Fabry-Perot cavity, as illustrated in Figure 1.10.
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Figure 1.10 Transmission spectrum of a FPI [67].

The slope of the constructive peak is determined by finesse. The larger the finesse
value, the sharper the constructive peak and the larger the distance between two separate
peaks, which means a higher resolution. The original finesse depends solely on the mirror
reflectance in an ideal FPI and is commonly approximated (for R > 0.5) by
71 • V/?
No =
.
*
1 -R

(1-3)
'

The higher the reflectance, the larger the finesse. The finesse can be degraded by
the defects of the mirror, such as imperfect flatness and imperfect parallelism [66, 67].
The ratio of the energy of reflected light to incident light from a dielectric is given
by the Fresnel equations. In the case of normal incidence,
2

R

E,

,n2
,2
H
~) ,
n2 + nx

(1-4)

where E r and E t are reflected and incident spectral intensities, respectively. The
spectrometer is the equipment used to measure the reflectance [67].
All of these technologies in the above review have shown excellent detection
sensitivity and ultra low DOL. However, these label-free optical techniques are plagued
by some or all of the following issues: expensive nanofabrication processes (i. e. PC
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sensors), complicated and expensive optical setup for operation (i. e. PC, LCORR, and
SPR sensors), and difficulty of miniaturization (i. e. LCORR and SPR sensors) for
microfabricating arrayed sensors for multiplexed detection. Even though the traditional
^FPI shows elegant sensitivity and performance for various sensing applications, its
limitations are obvious: limited sensing area due to the small surface areas of the planar
plates of the jiFPI, limited penetration depth of the excitation light in the sensing area,
and limited intensity of the transducing signal due to the optical power losses of the
reflected or transmitted light from the FPI at the interface of air and the FPI plates. These
issues contribute to the difficulty of making these platforms cost-effective and compact.

1.3

Previous Work and Problems

A new type of disposable label-free optical biosensors based on micromachined
polymer Fabry-Perot interferometers (jiFPIs) has been developed [68]. The schematic of
a white-light source operated jiFPI chemo/biosensor is given in Figure 1.11, showing
immobilized antibodies (Abs) on the surface of the Au-coated glass surfaceand the
binding between Abs and antigens (Ags).

FP cavity

Receptor (Ab)
Proteins (Ag)
Outlet

An thin film
Figure 1.11 Schematic of a PDMS based JJIFPI chemo/biosensor.
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This type of (iFPl is fabricated using polydimethylsiloxane (PDMS) plate and a
glass plate. The PDMS and glass plates serve as two FPI planar plates. The sensing
surface is the glass plate inside the FPI cavity, which is about 100 (im x 100 jam in area.
A fiFP cavity with a gap of 50

is formed between them, serving as the sensing area.

At the current stage, both plates do not have any thin film coating to enhance their
reflectivity like the traditional macroscale FPI or reported (xFPI. The fiber optics based
testing setup is illustrated in Figure 1.12.

/"VTo spectrometer

Optical fiber probe
•Illumination light

Center fiber to collect
reflected light

FPI chemo/biosensor

End surface of the
optical fiber probe

Figure 1.12 Optical setup of a FPI biosensor.

The customized optical fiber probe delivers the white-light to the sensor as well as
receiving the reflected transducing signals from the (iFPI sensor, which are coupled to a
spectrometer. The optical fiber probe consists of a tight bundle of seven optical fibers in a
stainless steel ferrule. The center fiber collects the reflected light while the outer six
fibers deliver illumination light to the FPI chemo/biosensor.
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The operation principle of this sensor is shown in Figure 1.13. Upon entering the
FPI cavity, the operation light undergoes multiple internal reflections between the two
FPI plates and interferences inside the cavity. The reflected and transmitted light goes
through the FPI as output transducing optical signals.

Light! . '

^
FP cavity

Reflected
light

nl

n

' Transmitted
light
Figure 1.13 Operational principle of a FPI.

As a result, modulated output transducing signals, such as reflected or transmitted
interference fringes, are generated as shown in Figure 1.14.

Protein A

Binding between Protein A
and porcine IgG
Wavelength (nm)
Figure 1.14 Inference fringe shift before and after binding.
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The shift is due to the effective index of refraction changes in the FPI cavity with
the binding between Protein A and Porcine IgG. More specifically, Protein A molecules
serve as the probes and are immobilized on one FPI plate surface. When a variety of IgG
antibodies are flowed through the cavity, they bind to Protein A, causing changes of the
effective index of refraction. The binding results in the interference fringes shift (AA),
which serves as the optical transducing signals.
The performance of the FPI is determined by its finesse F, which is related to the
free spectra range (FSR=AA) and the full-width at half-maximum (FWHM) 5X [67]. The
sketch of the optical system, including the optical fiber and the fiFPI for the modeling, is
illustrated in Figure 1.15.

Optical fiber

PDMS

Optical coupling between the fiber and FPI
Figure 1.15 Sketch of the optical system.

The system includes the optical fibers and the |iFPI device: the indices of
refraction of PDMS, medium in FPI cavity and glass are «/, «2 and
optical

fiber

probe

delivers

the

white-light

from

a

tungsten

A customized
halogen source

perpendicularly to a biochemical sensor. This probe also receives the reflected signals
from the sensor, which is eventually coupled to a spectrometer [67]. The loss of the
optical coupling between the fiber and jxFPI sensor needs to be considered.
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One may assume the loss coefficient of (aFPI cavity is L and the loss between the
fiber probe and jiFPI is L^er-i-Ph then, the reflected intensity l r from this system, coupled
to the spectrometer, is written as,
I, = /, exp(- 2(A "^ r ) x L n ^ m x /(/?_ mu ,, R ^ J ,
or

(1-5)

where
f(R

q
\ - '~ 2 + ^ fpi ~ 2r 1 r i L F P I cos{2kn 2 d)
a,r-PDKiS. airbus,
^ ^ ^ 2 _ ^^ ^ ^(2^ d) '
}

,. ^

r 2 = -r x = ———, r, =
, I,exp(-2(A-A ( l ) 2 / oj) is incident light intensity, A 0 is the
« 2 + «,
n2 + «3
center wavelength of the light source,

co

is the beam radius at the beam waist, f(R a i,-PDMs,

Rair-ghss) is the reflectivity from the ji FPI, Rair-PDMs and Rair-gtass are reflectivities at the

interface between air and PDMS, and air and glass, respectively, d is the gap size of FPI
cavity, and ni, ri2 and nj are the indices of refraction of PDMS, the medium in FPI cavity,
and glass, respectively.
The measured output signal from a (J.FPI device with air inside its cavity is given
in Figure 1.16 based on the model proposed in principle of FPI. The calculated
transducing signals with air in the FPI cavity match the measured signals quite well as
shown in Figure 1.16. Note that the intensity of the white-light source across the
wavelength range, from 360-2,500 nm, is not uniform. The envelope of the interference
fringes is the profile of the intensity of the white-light source.
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Figure 1.16 Calculated and measured transducing signals.

A protein-protein binding assay has been used to demonstrate the operation and
biomolecular detection capability of the polymer based

ji FPI

at room temperature. The

measured transducing signals for PBS, immobilized Protein A, Protein A bound with
Porcine IgG, Protein A bound with sheep IgG and Protein A bound with rabbit IgG have
been tested. The shifts in interference fringes are clearly observed, indicating differences
of effective refraction indices of these three different types of IgGs.
In previous work, a polymer based (J.FPI biochemical sensor had been developed
and its biomolecular detection capability demonstrated successfully. The simple, cost
effective, and disposable nature of this type of sensor is attractive for point-of-care
biodetection applications. The experiments show that DOL of this sensor is between 50
and 5 ng/ml for the rabbit IgG.
However, for biochemical sensing, a conventional (J.FPT has intrinsic limitations.
First, it has a limited sensing surface area (100 (J.m x 100 fxm), which means that binding
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sites available for biomolecules are limited, resulting in low transducing signals. Second,
the optical sensitive range/area is essentially limited only on the surface of the planar
glass plate. Finally, it has a limited intensity of the transducing signals due to the optical
power losses of the reflected light from the FPI at the interface of air and the FPI plates.
It is highly possible to enhance the sensitivity and detection of limit significantly by
introducing some nanostructures inside the FPI cavity [69, 70],

1.4

Dissertation Objectives

The aim of this dissertation research is to develop and investigate a novel
nanostructured Fabry-Perot interferometer which is able to realize ultrasensitive labelfree biodetection. First, a nanostructured Fabry-Perot interferometer will be introduced
and demonstrated. Then, Raman signal enhancement and interferometer signal
enhancement based on gold coating nanostructured devices will be demonstrated to
enhance optical transducing signals, including improving the finesse, the free spectral
range,improving the DOL and enhancing the intensity of output signal. Based on this
concept, a nanostructured device will be developed. Proof-of-concept demonstrations
using IgG-Protein Abiodetection will be performed first. Thereafter, further experiments
and experimental analysis will be carried out for ultrasensitive detection of a cancer
biomarker using this technical platform.

1.5

Organization of Dissertation

Chapterl introduced biosensors and their components and reviewed three major
types of label-free transduction mechanisms, which include an electrical biosensing
mechanism, a mechanical biosensing mechanism and an optical biosensing mechanism.
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Related work of developing biosensors that utilize electrical, mechanical, and optical
transductons has been reviewed. Advantages and disadvantages have been investigated
by comparing the previous work. Most recent examples of research on polymer based
[iFPI biosensors and their future have been presented. Chapter 2 will cover the materials
and equipment which will be used in later experiments.
Chapter 3 will introduce the design of nanostructured Fabry-Perot interferometer
based biosensors and the fabrication process. The prototype device will be evaluated
using several chemicals. Fourier transform will be performed on the measured optical
signals to facilitate the analysis ofthe transducing signals. Finally, the device will be
funetionalized for subsequent immunosensing.
Chapter 4 will investigate Raman signal enhancement and interferometer signal
enhancement based on gold coating nanostructured devices to enhance optical
transducing signals, including improving the finesse, the free spectral range, the DOL,
and enhancing the intensity of the output signal. Then, a finite element analysis (FEA) of
signal enhancement will be performed to simulate the signal enhancement.
Chapter 5 will indirectly confirm the shifts of interference fringes for label-free
biodetectionof IgG and BSA interaction using fluorescent imaging. A control experiment
incubating immunoglobulin G (IgG) on gold surface will be carried out to confirm the
small affinity of IgG to the gold coated sensing surface.
Chapter 6 will describe and investigate a protein-protein (Protein A and Porcine
IgG) binding assay based biosensor using this nanostructured Fabry-Perot interferometer
for proof-of-concept demonstration. The DOL will be tested for this biosensing technical
platform. Control experiments will be performed to check if Sea Block binds with Protein
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A or IgG to confirm that the biodetection is only specific to Protein A and IgG
recognition.
Chapter 7 will describe and investigate the application for the ultrasensitive labelfree detection of a cancer biomarker using this technical platform. Specifically, the
prostate cancer biomarker free prostate-specific antigen (f-PSA) will be detected with a
mouse anti-human PSA monoclonal antibody (mAb) as the receptor. The DOL of this
nanostructured FPI microchip for f-PSA and the upper detection range for f-PSA will be
determined. The control experiments will be carried out to demonstrate that the
immunoassay protocol used in the experiments shows excellent specificity and selectivity,
suggesting the great potential to detect the cancer biomarkers at trace levels in biofluids.
Chapter 8 will give the conclusion for the dissertation. Recommendations for
future work will be further discussed.

CHAPTER 2
MATERIALS AND EQUIPMENT
2.1

Materials

The assay reagents used in the experiments included Protein A (Pierce
Biotechnology, Inc.), bovine serum albumin (BSA) (Sigma-Aldrich, Co.), buffer solution
phosphate buffered saline (PBS) (Sigma-Aldrich, Co.), Sea Block (Pierce Biotechnology,
Inc.), Porcine, Rabbit and Goat IgG (Sigma-Aldrich, Co.) and free-PSA monoclonal
antibody (Anogen-YES Biotech Laboratories, Ltd.).
2.1.1

Immunoglobulin G
and Protein A
An antibody is usually a Y-shaped protein with large molecular weight. The

foreign targets, such as bacteria and viruses, are called antigens. Due to the existence of
antibodies, large foreign molecules, such as antigens, could be detected by theimmune
system, neutralized and then cleaned out of the body. Antibodies are specified to their
corresponding antigens with high affinity. In the field of clinical research, this feature
makes antibodies a good choice of biological agents for treating a variety of diseases [71].
The structure of an antibody is shown in Figure 2.1.
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Antigen
Antigen

Figure 2.1 Structure of an antibody [71].

An antibody usually has a Y shape. The arms of the Y shape have their unique
functions. The upper two arms consist of binding sites for antigens. This region is termed
the "fragment, antigen binding (Fab) region" [29], The base of the Y-shape contains the
function group, carboxyl group COOH, and is used for further binding. This region is
termed the "fragment crystallizable(Fc) region" [29],
As a type of antibody, IgG is specified to detect Protein A. This technology is
widely used in biological research. In this work, Porcine IgG is purchased from SigmaAldrich, Co.
Protein A is usually derived from the cell wall of staphylococcus aureus bacteria.
It has a large molecular weight of 40-60 kDa. The structure of Protein A is shown in
Figure 2.2.
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extern

periplasm
Figure 2.2 Structure of a protein molecule [72],

Due to its capability of binding with IgG, Protein A has been widely in
biomedical research. Its structure consists of five homologous Ig binding sites, each of
which could bind with different IgGs with different affinities. However, Protein A loses
its function when it is denatured.
In this work, Protein A was purchased from Pierce Biotechnology, Inc. Usually,
Protein A is first immobilized onto a substrate. The immobilized Protein A is used to
purify IgG from a mixture sample such as serum or ascites fluid [73],
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2.1.2

Bovine Serum Albumin and
Anti-Bovine Serum Albumin
Bovine serum albumin (BSA) is a serum albumin protein prepared from cows.

There is a lot of serum albumin in the human body and other mammals, making it
essential for body fluids. However, it is also harmful if there is too much serum albumin
in the body.
BSA has a molecular weight of 66.5 kDa. It has a high affinity and specificity for
the anti-BSA antibody. BSA has been widely used inthe pharmacological and
toxicological field [74], In this work, BSA was obtained from Sigma-Aldrich, Co. It was
diluted with PBS (pH=7.5) solution at several different concentrations of 50, 100, 500,
5,000 pg/mL. The analyte was anti-BSA IgG. In this work, anti-BSA Rabbit IgG and
anti-Rabbit Goat IgG were also purchased from Sigma-Aldrich, Co. They were prepared
by conjugating the IgG fraction of anti-bovine serum albumin (BSA) to cyanogen
bromide-activated agarose.
Secondary anti-BSA Rabbit IgG labeled with FITC was used to confirm the
binding between BSA and primary anti-BSA Rabbit IgG and verify the weak affinity of
primary anti-BSA Rabbit IgG to gold surface. In this work, secondary anti-BSA Rabbit
IgG labeled with FITC was purchased from Sigma-Aldrich, Co.
2.1.3

Phosphate Buffered Saline
and Sea Block
Phosphate buffered saline (PBS) was used to prepare the Protein A, IgG, and BSA

solutions. In this work, PBS was purchased from Sigma-Aldrich, Co. PBS was prepared
by mixing sodium and potassium chloride with small quantities of Na2HPC>4 and KH2PO4
in distilled or deionized water. It had the pH value of 7.5 at 25 °C.
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Sea Block was purchased from Pierce Biotechnology, Inc. It is a protein based
blocking buffer prepared from steelhead salmon serum in PBS. It is widely used as a
blocking agent in immunohistochemistry and biological detection using mammalian
samples.
2.1.4

SU8 and Poly Dimethvlsiloxane
SU8 is a photosensitive epoxy-based polymer. SU8 is becoming widely used in

the fields of micromechanics and microfluidics mainly by soft lithography [75, 76], The
structure of a SU8 molecule is shown in Figure 2.3.

0
1
1
ch2

0
11
CH,

0
1
1
CHj

chn
> >
ch2

CHv

CHV
1
)°
CHj

1 )°
CHj

0
i
1
CH,
1
CHv
1
)°
CHj

Figure 2.3 Structure of a SU8 molecule [77].

A structure of a SU8 molecule consists of eight epoxy groups. SU8 is a negative
photo resist. Upon exposure to UV light, the SU8 molecules cross link, making the mold
solidified. Usually, SU8 can be spun up to a thickness of 0.1 (j.m to form high aspect ratio
structures [78], In this work, SU8 2050 is purchased from MicroChem, Corp. and was
used for fabricating the mold for the bio interaction chamber on a silicon wafer.
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Poly (dimethylsiloxane) (PDMS) was well known as a silicon-based organic
polymer. It has such biocompatibility as nonirritating to skin, no adverse effect on mice
or rabbit. It is highly hydrophobic, with contact angles from 90° to 120°. Its melting point
is above 40°. It has been widely used to make the replica from SU8 mold to construct
microfluidic devices [79]. The structure of PDMS is shown in Figure 2.4.

Figure 2.4 Structure of PDMS [80].

PDMS has such advantages as cost effective, easy to fabricate and optically
transparent. These features make PDMS suitable for fabricating optically integrated
devices using micro molding [79, 81]. PDMS is also inert to many chemicals and non
toxic and non-flammable. These features make PDMS suitable for biomedical testing

[82].
In this work, PDMS (MicroChem, Corp.) was used to bond with the substrate to
form the sensing chamber and micro fluidic channels. The surface of PDMS was
hydrophobic after being cured. The surface of PDMS was treated with oxygen and
bonded with the substrate.
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2.1.5

Rhodamine 6G
Rhodamine 6G (R6G) is a chemical compound and its structure is shown in

Figure 2.5.

Figure 2.5 Structure of Rhodamine 6G [83].

R6G is a tracer dye and also a laser dye. As a tracer dye, its fluorescent efficiency
is amongst the highest, and it is highly stable [84], It is easy and inexpensive to detect
with fluorometers. Therefore, R6G has been extensively used in environmental
monitoring, food analysis, and biological research [85],
As a laser dye (also called gain medium), it has the characterization of low cost,
higher photochemical stability, and lower lasing threshold [86], Noble metals such as
gold, silver can cause multiphoton induced emission on roughened surfaces. R6G can
significantly enhance themultiphoton induced emission [87].
In this work, R6G (Lightning Powder Company, Inc.) was used to evaluate the
optical signal enhancement capability of the Au-coated nanopore layers by measuring its
Raman signals. A 250

R6G solution was prepared by mixing 0.12 mg R6G powder

with 1 mL DI water. Substrates was immersed in R6G aqueous solution and incubated.
Then, Raman spectroscopy measurements were performed on these substrates.
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2.1.6

Free Prostate Specific Antigen
Mouse anti-human PSA monoclonal antibody (detector mAb) (catalog # T40081B,

clone # CHYH2), ELISA kits for human f-PSA (catalog # 10050) were obtained from
Anogen-YES Biotech Laboratories, Ltd. (Mississauga, Canada). The 10 ng/mL free-PSA
standard solution was used for the preparation of free-PSA solutions with lower
concentrations using sample dilutant provided in the ELISA kit. The 10 ng/mL free-PSA
standard solution was prepared in a protein matrix solution according to the WHO
standard by the vendor. The concentrations of diluted free-PSA included 0, 5, 10, 50, 100,
500, 5000 pg/mL for the experiments. Absolute ethanol was obtained from Thermo
Fisher Scientific, Inc., USA. Dionized (DI) water is obtained from a DI water purification
system (Millipore, France).

2.2

Equipment

The experimental setup is shown in Figure 2.6. It includes a white-light source,
optical probe, optical fibers, stage, syringe pumps, spectrometer, and data analysis system.
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Figure 2.6 Experimental setup for optical testing.
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2.2.1

White-Light Source
The white-light source shown in Figure 2.7 was purchased from Ocean Optics,

Inc. It is a tungsten halogen white-light source (LS-1), with a spectrum range from 360
nm to 2,500 nm. The LS-1 is featured with an SMA 905 connector, which can be easily
coupled to optical fibers with SMA 905 connectors.

Figure 2.7 Photograph of a white-light source.

2.2.2

Spectrometer
The spectrometer was also purchased from Ocean Optics, Inc. The spectrometer

(USB4000) has a resolution of 0.21 nm and the smallest integration time is 3 ms. The
USB4000 is featured with an SMA 905 connector, which can be easily coupled to optical
fibers with SMA 905 connectors, as shown in Figure 2.8.
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Figure 2.8 Photograph of a spectrometer.

2.2.3

Optical Fiber and Probe
The optical fiber probe was customized from Ocean Optics, Inc. The optical fiber

probe consists of a tight bundle of seven optical fibers in a stainless steel ferrule, as
shown in Figure 2.9. The center fiber was used to collect the reflected light while the
outer six fibers deliver the illumination light to the FPI chemo/biosensor. This optical
fiber probe delivers white-light from a tungsten halogen source perpendicularly to a
biochemical sensor. This probe also receives the reflected signals from the sensor, which
was eventually coupled to a USB4000 spectrometer.

Optical fiber probe
Center fiber to
reflected light

FPI chemo/biosensor

Illumination light

End surface of the
optical fiber probe

Figure 2.9 Schematic of an optical testing setup.
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2.2.4

Opto-Mechanical Components
According to the manufacturers, opto-mechanical components should be set up on

top of an optical platform (Newport, Inc.) to hold the optical fiber probe. The optical fiber
probe was fixed on a probe holder kinematic mount with three-screw adjustment
(Edmund Optics, Inc.), as shown in Figure 2.10. The holder can adjust the angle of the
probe. Other posts, holders and adaptors were purchased from Thorlabs, Inc.

Figure 2.10 Probe holder.

2.2.5

Raman Microscope
SENTERRA Raman Microscope (Bruker Optics, Inc.) was used to measure the

Raman signals of R6G on glass, AAO, and Au-coated AAO substrates, respectively. The
system is shown is Figure 2.11.

Figure 2.11 Photograph of a Raman microscope.

In this Raman spectroscopy, a 785 nm laser was used for exciting Raman signals.
This instrument incorporates a patented automatic fluorescence rejection (AFR) method
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for eliminating fluorescence from samples, thereby increasing the ratio of signal-to-noise
of Raman signals.
2.2.6

Sputter Coater
The sputtering machine Cressington 108 Sputter Coater used to sputter gold was

made by Cressington Scientific Instruments, Inc.
The sputter coater can work in two modes, either manual or automatic. In the
automatic mode, there are two options. The first option is multi-thickness mode (MTM).
In this option, the coating process stops when assigned thickness is reached. The second
option is timer-control mode. In this option, the coating process stops when assigned time
was reached.

CHAPTER 3
DESIGN, FABRICATION, AND EVALUATION
3.1

Design

A schematic of two microfluidic nanostructured FPI devices on a single chip is
illustrated in Figure 3.1. Each device consists of a PDMS plate, an Au-coated nanopore
layer, and a glass plate. The Au-coated nanopore layer is anchored inside the FPI cavity.
The average size of nanopores before Au coating is -50 nm in diameter and the gap size
of the FPI cavity is 50 p.m. Note that for some nanostructured (J.FPI devices, the nanopore
layer is not Au coated for comparison in some experiments.

Nanopore-plasmonic
substrate
j|
PDMS laver
\
*

Sample/*
etecti<jjg£S

Figure 3.1 Schematic of two nanostructured FPIs.
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3.1.1

Microfluidic Chip
For conventional immunoassays, probe molecules and target molecules are

pipetted to the wells of the immunoassays and incubated for reaction without stirring.
One of the disadvantages of conventional immunoassays is the relative large amount of
samples, which are expensive. This problem can be solved by using the micro or
nanotechnology to reduce the volume of the samples to nano- or picoliters. The other
disadvantage of conventional immunoassays is the relatively long incubation time, which
occurs because of its dependence on the diffusion time. The large molecules used in the
experiments such as IgGs (150 kDa), diffuse very slowly in the wells of the
immunoassays. The relation between the diffusion time and the diffusion distance inside
a well follows the Einstein-Smoluchowski equation, as shown in Eq. (3-1)
d=(2Dt)m,

(3-1)

where d is the diffusion distance, t is the diffusion time, and D is the diffusion coefficient.
For IgGs with a diffusion coefficient D of 4xl0" 7 cm 2 /s, it takes about three and
one-half hours to diffuse 1 mm distance, which is the order of distance in a well of an
immunoassay. However, the much smaller chamber dimensions, such as 50 ^m, in this
design, could reduce the diffusion distance, and therefore, the diffusion time to less than
1 min. Thanks to the micro- and nanotechnology, microfluidic chips based on the
polymer PDMS was used to shrink the dimensions of the sensing chamber and speed up
the detection and analysis process.
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3.1.2

Nanostructured Fabry-Perot
Interferometer
The embedded nanopores inside the FPI cavity were used for increasing the

sensing surface area, namely increasing the number of binding sites for the biomolecules.
The cross section view of the nanostructured FPI biosensor is shown in Figure 3.2.

Broadband light source
(iFP cavity

Reflected light

Figure 3.2 Cross section view of a nanostructured FPI.

The sensing surface area includes the top, bottom surfaces of the nanopore layer,
and sidewalls of the nanopores. The thickness of the nanopore layer is 3 (im. Therefore,
the penetration depth of the light can be 3 fim. In other words, the optical sensitive range
had been extended to 3 |im from the top surface of the nanopore layer. The Au thin film
that is coated on the nanopore layer and sidewalls of the nanopores was used for
enhancing the optical signal intensity.

3.2

Fabrication

The fabrication of a nanostructured Fabry-Perot interferometer includes the
PDMS based microfluidic chip, the porous anodic aluminum oxide, the gold thin film
coating, and the assembly of the chip.
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3.2.1

Fabrication of PDMS Based
Microfluidic Chip
The device was fabricated using an inexpensive and rapid soft lithography process

[88], First, SU8 was spin coated on a standard 100 mm diameter silicon wafer. An optical
micrograph of the SU8 mold of one single (iFPI device showing the integrated channel
for sample delivery to the FP cavity is given in Figure 3.3. The diameter of the FPI plate
was 250 ^m. The thickncss of the SU8 mold of the device was 50 ^.m.

Figure 3.3 Optical micrograph of a SU8 mold.

A 50 pm high SU8 mold was formed on the silicon wafer as shown in Figure 3.4
(A). PDMS was casted on the mold, followed by a 1.5 hr curing at a temperature of 65 °C,
as shown in Figure 3.4 (B). Then, the PDMS layer was peeled off from the mold. After
this step, the input and output channels were made in the PDMS layer using a 1.5 mm
diameter hole puncher, as shown in Figure 3.4 (C).
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SU 8 mold

PDMS replica

(B)

I

PDMS layer

(C)
Figure 3.4 Fabrication process of a PDMS microfluidic chip.

An optical image of a 2 x 2 PDMS FPI device is shown in Figure 3.5. The cavity
length is 50 (J.m. The diameter of each FPI chamber is 250 |im.

Figure 3.5 Optical micrograph of 2 x 2 PDMS-FPIs.
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3-2.2

Fabrication of Porous Anodic
Aluminum Oxide
The device consisted of a PDMS layer and an Au-coated nanopore layer. The

nanopore layer was a porous anodic aluminum oxide (PAAO) layer. The PAAO layer
was fabricated from an aluminum substrate using a standard two-step anodization process
[89], The fabrication process of the nanostructures began with a polished aluminum plate,
as shown in Figure 3.6 (A). Then, the nanopores were formed using two-step anodization
process, as shown in Figure 3.6 (B). A 5

A

Cr adhesion thin film was sputter coated on

AAO, as shown in Figure 3.6 (C). Finally, a 50

A

Au thin film was sputter coated, as

shown in Figure 3.6 (D).

Aluminum

(A)

I
Porous AAO

(B)

I

Sputter Cr

nnnnnnnnnn
(C)

i

SputterAu

nnnnnnnnnn
(D)
Figure 3.6 Fabrication process of nanostructures.
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Major steps for the anodic aluminum oxide (AAO) fabrication included polishing
of the aluminum substrate, two-step anodization process, and release of the AAO barrier
layer.
The aluminum plate was purchased from Alfa Aesar, Inc. During the initial
experiment, the aluminum plate was first cut into small square pieces while trying to
better perform the fabrication process. The SEM image of the close-up of a bare
nanopore structure layer is shown in Figure 3.7.

Figure 3.7 Close-up SEM image of a bare nanopore layer.

It has arrayed pores with size of about 50 nm in diameter. The size of the
nanostructure as well as the space among them, can be tuned by changing the operational
parameters during the fabrication process.
It should be noted that depending on specific applications, the size of
nanostructure as well as the space among them, can be readily tuned during the
fabrication process from several ten nanometers to several hundred nanometers (e. g.,
100-200 nm) in diameter [89], Hence, the nanopores are big enough and can provide
sufficient volumes and surface areas for biomolecular interaction inside them.
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3.2.3

Gold Thin Film Coating
After fabricating the nanostructures, in order to enhance the optical transducing

signal, a thin layer of gold was coated on top of the nanopore layer using sputter coating.
First, a layer of 5

A

thick Cr was deposited onto PAAO as an adhesive layer. Then, a

layer of Au thin film was deposited. Au thicknesses were from 5

A

to 100

A

in these

experiments. For comparison, close-up SEM images of a bare AAO layer and an Aucoated AAO layer are given in Figure 3.8. As shown, the Au thin film on AAO layer
clearly consists of Au nanoparticles with size in the range of 10-20 nm. The gold
nanoparticles in this structure play the major role in enhancing the intensity of the optical
signal due to the localized surface Plasmon resonance effect [90, 91].

Figure 3.8 SEM images of bare AAO and Au-coated AAO.

In order to have a three dimensional view of the nanostructure, an AFM image of
a topside view of the nanopore layer and a 3D AFM image of the nanopore layer are
given in Figure 3.9, showing the nanopores uniformly distributed. On the left, there is a
top side view of the nanopore layer. On the right, there is a 3D AFM image of the
nanopore layer.
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Figure 3.9 AFM images of nanopores.

3.2.4

Assembly of the Biosensing
Platform
Finally, the PDMS layer and the Au coated nanopore layer were bonded together

to complete the device fabrication after an oxygen plasma treatment. The input and
output wells were made in the PDMS layer for the delivery of samples to the nanoporeFPI or Au-nanopore-FPI devices.
The fabrication process flow and the assembly of the nanostructured FPI
biosensor began with the SU8 mold by the soft lithography process, as shown in Figure
3.10 (A). Then, PDMS microfluidic channel was formed using the SU8 mold, as shown
in Figure 3.10 (B). The input and output channels were punched with a 1.5 mm diameter
hole puncher, as shown in Figure 3.10 (C). The nanopore layer began with a polished
aluminum plate using a two-step anodization process, as shown in Figure 3.10 (D). A 5A
Cr adhesion thin film was sputter coated on AAO, as shown in Figure 3.10 (E). Then, a
50

A

Au thin film was sputter coated on top, as shown in Figure 3.10 (F). Finally, the

PDMS microfluidic chip was bonded with the Au coated AAO to form the biosensor chip,
as shown in Figure 3.10 (G).

Porous AAO

SU 8 mold

(D)

(A)

i

i

Sputter Cr
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nnnnnnnnnn
(E)

(B)

1

c

i

Sputter Au
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PDMS laver

•

(F)

(C)

Bond

(G)

Figure 3.10 Assembly process flow of the biosensing platform.

The optical micrograph of the assembled polymer Au-nanopre-FPI is shown
Figure 3.11, compared with a nickel.

Input

PDMS

Figure 3.11 Photograph of a PDMS-based nanostructured FPI.
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The arrayed devices can be readily and rapidly batch-fabricated, offering a cost
effective and disposable biosensing technical platform with high throughput.

3.3

Evaluation

The prototype Au-nanopore-FPI sensor has also been evaluated with some
chemicals such as IPA, ethanol, and water. As expected, clear shifts of the interference
fringes has been observed in Figure 3.12 due to their different refractive indices. The
coated Au thickness was 20
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Figure 3.12 Evaluation of a prototype device.

In Table 3.1, the average fringe peak shifts relative to air inside the FPI cavity are
summarized. The average shift was obtained by averaging the shift of the fringe peaks
between the 400 nm to 1100 nm spectrum window. Given the resolution of the USB4000
Spectrometer is 0.02 nm, the measurement error for the fringe peak shift is ± 0.01 nm. It
should be noted that if the nanopores are blocked due to thicker Au coating, the
interference fringes will disappear as observed in these experiments. This result
confirmed that the nanopores play an important role in the formation of interference
fringes.
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Table 3.1 Fringe peak shift and EOT change.

Water

Average interference peak shift
relative to air (400 nm-1100 nm)
24.94 ± 0.01 nm

Calculated EOT change
relative to air (nm)
517.8 nm

IPA

37.09 ±0.01 nm

776.7 nm

Methanol

22.67 ±0.01 nm

258.9 nm

Material

In order to simplify the analysis of transducing signals, Fourier Transform (FT)
was performed on measured optical signals. For an FPI device, the wavelength (A) of the
peak maxima in the interference spectrum is given by: ml=2nL, where m is the spectral
fringe order, n is the effective refractive index of nanostructure layer and its contents in
the cavity, L is the geometric thickness of nanostructure layer and FPI cavity gap. 2nL
represents the effective optical thickness (EOT) and can be obtained from FT of
measured spectrum in Figure 3.12 [92], As a result, only a single peak was presented for
each case, as shown in Figure 3.13, in which the x-axis was EOT [92]. Changes of EOT
for different chemicals relative to air inside the FPI cavity are summarized in Table 3.1.
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Figure 3.13 The FT plot for evaluation.
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3.4

Functionalization

The antibody IgG is usually a Y-shaped protein with large molecular weight. The
foreign targets such as bacteria and viruses are called antigens. Due to the existence of
antibodies, large foreign molecules such as antigens could be detected by the immune
system, neutralized, and cleaned out of the human body. Antibodies are specified to their
corresponding antigens with high affinity. In the field of clinical research, this feature
makes antibodies a good choice of biological agents for treating a variety of diseases [71].
The schematic of an antibody structure is shown in Figure 3.14. The arms of the Y-shape
have their own unique functions. The upper two arms consist of binding sites for antigens.
This region is termed the "fragment, antigen binding (F a b) region" [29]. The base of the
Y-shape contains the function group, carboxyl group COOH, and is used for further
binding with the antigen. This region is termed the "fragment crystallizable (F c ) region"
[29],

Antigen binding sites

"Fab region

-Fc region

Figure 3.14Schematic of an antibody structure [29].
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In this work, the part of the antibody used to detect the antigen was the Fc domain
of IgG. It contained the base as the binding site, which was used to bind with Protein A.It
should be noted that different from the conventional immobilization of IgG first and
binding with Protein A sequence, Protein A was immobilized due to its high affinity with
gold surface and used to orient IgG.
As a type of antibody, IgG is specified to detect the antigen Protein A. Protein A
is usually derived from the cell wall of staphylococcus aureus bacteria. It has a large
molecular weight of 40-60 kDa. Due to its capability of binding with IgG, Protein A has
been widely used in biomedical research. Its structure consists of five homologous IgG
binding sites, each of which could bind with different IgGs with different affinities.
However, Protein A loses its function when it is denatured.
Protein A was first immobilized onto a substrate. Then, the immobilized Protein
A was used to purify IgG from a mixture sample such as serum or ascites fluid [73]. At a
pH value of 7.4, Protein A is negatively charged [29]. It can be immobilized on gold
surface by physical forces. Initially, PBS was pumped into the FPI cavity to rinse the
device. Thereafter, the Protein A solution is applied into the device and allowed to stay
for 30 min at room temperature, as shown in Figure 3.15 (A). The Protein A had
sufficient time to bind to the Au-coated surface of the nanopore structures and served as
capture proteins. The unbound Protein A was then washed away using PBS solution. The
washing routine consisted of at least three cycles of pumping PBS through the device and
each cycle lasting for 3mins. The measurement of the optical transducing signals was
taken at each cycle for three times and checked for measurement repeatability. In order to
block the sites on the nanopore layer unoccupied by Protein A, the solution was pumped
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next into the device. The solution was allowed to stay for 15 mins at room temperatureas
shown in Figure 3.15 (B). Then, the solution was pumped out and the wash and
measurement routine was performed. Thereafter, the IgG solution was applied onto the
device and allowed to settle and bind with Protein A for 15 to 30 mins at room
temperature as shown in Figure 3.15 (C). The measurement was taken after washing the
excess unbound IgG using PBS solution.

Protein A

*

, a . •

(A)

Sea Block

fTfTfTfTfTf
(B)
IgG

(C)
Figure 3.15 Functionalization process.

In this surface modification process, the capture probe Protein A was used to bind
with the antibody IgG and used to orient IgG.
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3.5

Summary

In summary, a polymer-based nanostructured-FPI device has been developed and
fabricated, its performance evaluated, and the device functionalized for subsequent
immunosensing. The nanostructured-FPI device offered some unique properties such
asincreased sensing area, extended penetration depth of the excitation light, and the
tremendous amplification of the optical transducing signals. It is anticipated that this new
type of nanostructured-FPI device can offer an ultrasensitive (e. g., femtomole) technical
platform forlabel-free biosensing. The simple, cost-effective, and disposable nature of
this type ofsensor is attractive for rapid point-of-care and field biodetection applications
as well. Fourier Transform of the measured spectrum can simplify the data analysis since
only one single peak presents in its corresponding plot for different samples whose x-axis
coordinate is the EOT of the nanostructure layer and the gap size of the FPI cavity.
Finally, the device has been functionalized for subsequent immunosensing.

CHAPTER 4
ENHANCEMENT OF OPTICAL
TRANSDUCING SIGNALS
4.1

Raman Signal Enhancement

To analyze the signal enhancement mechanism for the Au-coated nanostructured
FPI, two methods can be used. One is to measure the near field optical intensity
distribution directly using a near field scanning optical microscope [93]. The other is the
indirect measurement which can be achieved by measuring the Raman signal
enhancement of molecules on the nanostructure in the optical far field [94].
The Raman signals of R6G in Figure 4.1 of the same concentration of 250
have been obtained on Au-coated AAO, AAO, and glass substrates, respectively.

6000
Glass substrate
& 4000

-— AAO
Au-coated AAO
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0
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Raman shift (1/cm)
Figure 4.1 Measured Raman spectra of R6G.

52

53

A SENTERRA Raman microscope was used to measure the Raman signals of
R6G on glass, AAO, and Au-coated AAO substrates, respectively. In this Raman
spectroscopy, a 785 nm laser was used for exciting Raman signals. This instrument
incorporates a patented AFR method for eliminating fluorescence from samples, thereby
increasing the ratio of signal-to-noise of Raman signals. R6G was used to evaluate the
optical signal enhancement capability of the Au-coated nanopore layers by measuring
their Raman signals. A 0.12 mg of R6G powder was mixed with 1 mL DI water to get a
250 juM R6G solution. A glass substrate, an AAO substrate, and an Au-coated AAO
substrate were immersed in a R6G aqueous solution for 30 mins, separately. Thereafter,
all of the three substrates are rinsed with DI water rigorously. Then, they were dried in a
vacuum dryer for 1 hr at room temperature before Raman spectroscopy measurements
were performed on these substrates.
As a result, the Raman signal of R6G was amplified significantly on the Aucoated AAO. The result indicated that the optical signal enhancement was enabled by the
nanoscale roughness of the Au thin film coated on the nanopore structures due to the LSPR [70],

4.2

Interferometer Signal
Enhancement

In order to examine the optical transducing signals of a gold thin film coated
nanostructured FPI, a comparative experimental study ona conventional |iFPI and
nanostructured FPIs (with and without Au thin film coating) was carried out. The testing
setup is shown in Figure 4.2.
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Optical fiber probe
Center fiber to collect
reflected light

FPI chemo/biosensor

Illumination light

End surface of the
optical fiber probe

Figure 4.2 Testing setup of optical signal enhancement.

An isometric sketch of a nanostructured FPI is shown in Figure 4.3. All the FPIs
had the same FPI cavity size of 50 ^m.

Figure 4.3 Isometric sketch of a nanostructured FPI.
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For the nanostructured FPIs, one nanostructured FPI had an Au-coated nanopore
layer and the other had the same nanopore layer but without Au coating inside its FPI
cavity. Prior to any addition of fluid, optical transducing signals of each device were
compared with air inside FPI cavities. Optical transducing signals were from three
devices with a conventional ^iFPI, a nanostructured FPI without gold coating, and a
nanostructured FPI with a 50

A

gold coated thin film layer. The optical transducing

signal was amplified significantly for the gold coated device as shown in Figure 4.4.
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Figure 4.4 Enhancement of optical transducing signals.

Systematic experiments found that an Au-coated nanostructured FPI with a
nanopore size of 50 nm had around twenty times improvement in FSR, around two times
improvement in finesse, and around four times improvement in contrast of optical
transducing signals over a traditional fj.FPI even without any device performance
optimization. The FSR of a conventional jaFPI was approximately 3 nm, which was
determined by the 50 ^im of the FPI cavity gap. In contrast, the FSR (around 60 nm) of a
nanostructured FPI was essentially determined by the geometrical dimensions (nanopore
size, pitch, and depth) of the nanopore layer. The comparison of these optical parameters
of different types of devices is summarized in Table 4.1.
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Table 4.1 Comparison of optical parameters.

FSR

Finesse

Output contrast

uFPI

Low

Low

Low

FPI w/o Au

20 x

Low

Low

FPI w/Au

20 x

2x

4x

4.3

Finite Element Analysis
of Signal Enhancement

The simulation for the signal enhancement by arrayed nanopores was carried out
using COMSOL. The module used was the electromagnetic wave module. The preset
study was in frequency domain. The equation solved was the Maxwell equation. The
parameters are shown in Table 4.2.

Table 4.2 Global parameters.

Name

Expression

Description

na

1

Refractive index, air

nb

1.77

Refractive index, alumina

LamO

600 nm

Wavelength

fD

cconst/lamO

Frequency

The simulation result for Au-coated nanopores is shown in Figure 4.5. Due to the
nanoscale roughness of the Au thin film, the transducing signal was greatly amplified.
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Figure 4.5 Illumination profile surrounding Au-coated nanopores.

The simulation result for bare nanopores is shown in Figure 4.6. Compared with
the illumination profile for Au-coated nanopores, there is negligible enhancement.
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Figure 4.6 Illumination profile surrounding bare nanopores.

The electric field norm means the length of the electric field vector in COMSOL
[95]. For a 50 nm diameter and a 100 nm distance from pore to pore at the wavelength of
600 nm and the gold thickness of 5 nm, the ratio of the electric field norm of Au-coated
nanopores to that of bare nanopores is approximately twenty times. The intensity of
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reflected light is the square of the electric field norm. Therefore, the enhancement of the
light intensity is approximately 400 times.
In order to get a white-light spectrum, simulation for different wavelengths was
performed. The wavelength ranged from 500nm to 800nm, with a step size of lOOnm.
Enhancements for different wavelengths are summarized in Table 4.3.

Table 4.3 Enhancements for different wavelengths.

Wavelength (nm)

Enhancement

500

385.7532

600

377.7853

700

369.8852

800

363.0092

The relationship between intensity enhancementsand wavelengths has been
plotted in Figure 4.7. In the white-light range, the 5 nm thick gold coated arrayed
nanopores with a diameter of 50 nm and a distance of 100 nm from pore to pore had
approximately 400 times enhancement for the light intensity. There was a slightly more
enhancement for a shorter wavelength.
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Wavelength (nm)

Figure 4.7 Relationship between enhancements and wavelengths.

Enhancements for different thicknesses are summarized in Table 4.4. The
relationship between enhancements and thicknesses has been plotted in Figure 4.8.
Among 2 nm, 5 nm, and 8 nm thicknesses, the 8 nm thick Au-coated structure has the
greatest enhancement.

Table 4.4 Enhancements for different gold thicknesses.

Thickness (nm)

Enhancement

2

267.5057

5

377.7853

8

489.7280

60

B 400
B 350
w 300

Thickness (nm)

Figure 4.8 Relationship between enhancements and thicknesses.

In order to study the effect of different nanopore structures, numerical analysis for
different pore diameters and pitch sizes was carried out. Pitch is the distance from pore to
pore. Pitch ratio is defined as the ratio of the pitch to the diameter of the nanopore.
Enhancements for 50 nm and 100 nm diameter nanopores are shown in Table 4.5 and
Table 4.6, respectively.

Table 4.5 Enhancements for 50 nm diameter nanopores.

Pitch ratio

Enhancement

2

378

3

671

4

1226
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Table 4.6 Enhancements for 100 nm diameter naonpores.

Pitch ratio

Enhancement

2

214

3

574

4

1473

The relationship between enhancements and pitch ratios is plotted in Figure 4.9.
Among diameters of 50 nm and 100 nm, and pitch ratios of 2, 3, and 4, the nanostructure
with a diameter of 100 nm and a pitch ratio of 4 had the greatest enhancement.
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Figure 4.9 Relationship between enhancements and pitch ratios.

4.4

Summary

In summary, experiments for enhancements of optical transducing signals were
carried out by both the Raman spectroscopy and the Fabry-Perot interferometer.
Enhancements of Raman signals indirectly confirmed enhancements of optical
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transducing signals. The FEA of the intensity distribution for arrayed nanopores was also
performed. The calculated results confirmed the great enhancement of the optical
transducing signals using the Au-coated nanopores.

CHAPTER 5
USEING FLUORESCENT IMAGING TO
CONFIRM FRINGE SHIFTS
5.1

Overview

The flow chart and the photograph of the experimental setup are shown in Figure
5.1 and Figure 2.6, respectively.

Light source

Optical fiber
wmmmmm} FPI chip

Optical fiber
Spectrometer

Optical
Samples

transducing
signal

Waste

Control unit

Data analysis
system

Figure 5.1 Flow chart of the experimental setup.

Before starting actual experiments, the small affinity of IgG for gold surface
compared with the affinity of BSA for gold surface needed to be confirmed.
Confirmation step began with incubating a 0.5 mg/mL anti-BSA rabbit IgG (diluted in
PBS) on gold surface for 45 mins. Then, the gold surface was rinsed with PBS to wash
away unbonded anti-BSA rabbit IgG. The second incubation was done with 0.5 mg/mL
of anti-rabbit goat IgG labeled with FITC fluorescent dye (diluted in PBS) on the
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previous surface for 45 mins. Finally, the gold surface was rinsed with PBS to wash away
unbonded anti-rabbit goat IgG. The measured interference fringe result showed that there
was no interference fringes shift before and after the incubation of anti-BSA rabbit IgG
on the gold surface. This whole process was also monitored under a fluorescence
microscope, and the observation did not show any kind of fluorescent signal. The absence
of shift in the interference fringes and the absence of any kind of fluorescence signal
confirmed that IgG exhibited a relatively small affinity for gold surface at pH=7.5.The
experimental process for BSA detection is described in Figure 5.2.

BSA

V
Au
thin film
•L
(A)
Anti BSA
rabbit IgG

^ ii )i
(B)
Anti rabbit
goat IgG-FITC

(C)

Figure 5.2 Experimental process for BSA-IgG detection

The actual experiment began with washing the surface of the nanostructured
Fabry-Perot interferometer based biosensor, as shown in Figure 5.2 (A). A 0.5
mg/mLBSA (diluted in PBS) solution was pumped into the device to ensure the
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nanostructure sensing surface was fully occupied by BSA, as shown in Figure 5.2 (B).
The incubation time was 45 mins. This was followed by three cycles of rigorous PBS
rinsing. Then, a primary antibody, anti-BSA rabbit IgG, was pumped into the device and
allowed to incubate for 45 mins, as shown in Figure 5.2 (C), followed by PBS rinsing.
Thereafter, a secondary antibody, anti-rabbit goat IgG labeled with FITC fluorescent dye,
was pumped into the device to ensure the binding of secondary antibody to the primary
antibody, as shown in Figure 5.2 (D). The incubation time was 45 mins and followed by
three cycles of rigorous PBS rinsing.

5.2

While shifts of

Indirect Confirmation of
Biosensing Signals
interference fringes from

a

nanostructured Fabry-Perot

interferometer based biosensor were optically monitored in real time, their corresponding
fluorescent images were obtained at the same time to indirectly confirm the biosensing
signals.
5.2.1

Shift of Fringes for
Biodetection
The experimental process was the same as described above. This whole process

was monitored by a spectrometer in real time. The interference fringes for each step of
the biointeractions are shown in Figure 5.3.
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Figure 5.3 Optical transdusing signals for BSA-IgG detection.

The clear shift between the primary IgG anti-BSA rabbit IgG and BSA indicated
there was binding between the primary IgG and BSA. The clear shift between the
secondary IgG anti-rabbit goat IgG labeled with FITC and the primary IgG indicated
there was binding between the primary IgG and the secondary IgG as well.
5.2.2

Fluorescent Imaging
for Biodetection
In order to indirectly confirm shifts of interference fringes from the experiment

above, their corresponding fluorescent images were simultaneously obtained.
The whole experimental process was monitored under a fluorescence microscope
at the same time, and fluorescent images are shown in Figure 5.4.
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Figure 5.4 Fluorescent images for BSA-IgG detection.

Figure 5.4 (A) is a fluorescence image taken after applying BSA to the sensing
surface of the biosensor. Figure 5.4 (B) is a fluorescence image taken after binding the
primary IgG anti-BSA rabbit IgG to BSA treated sensing surface. Figure 5.4 (C) is a
fluorescence image taken after binding the secondary IgG anti-rabbit goat IgG labeled
with FITC and the primary IgG. From the images, one may see that no fluorescent signals
were detected before the secondary IgG treatment, and clear fluorescent

signals were

detected after the secondary IgG treatment. This result indicated there is immobilization
of BSA to the sensing surface and binding between the primary antibody and BSA.
The fluorescent images indirectly confirmed shifts of interference fringes from the
experiment work for BSA and anti-BSA IgG interaction.
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5.3

Summary

In this chapter, the control experiment was first carried out to confirm the small
affinity of IgG to the gold coated sensing surface. Then, using fluorescent images, shifts
of interference fringes for IgG and BSA interaction were indirectly confirmed.

CHAPTER 6
A PROTEIN BASED BIOSENSOR
FOR IGG DETECTION
6.1

Overview

The schematic of a nanostructured FPI sensor was given in Figure 3.1. The
biosensor was fabricated from PDMS and glass plate with its FPI cavity formed between
them. Different from a conventional FPI, inside its cavity there was a layer of nanopore
structures, serving as the biosensing area. This nanopore layer increased a great deal of
the sensing area, thus enhancing the sensitivity of the senor greatly. In addition, this layer
of nanopore was coated with Au thin film, typically ranging in thickness of several tens
of angstroms. Due to the nanoscale roughness of the Au thin film, the transducing signal
(e. g., reflected light) was amplified tremendously. Its operation procedure was reported
previously by T. Zhang et al. [61]. The ease-of-fabrication of arrayed FPI sensors on a
single chip facilitated its applications for highly multiplexed biosensing.
A brief explanation of the operation principle was given as follows. As a
refractive-index sensitive optical sensor, both immobilization of probes on the nanopore
surfaces and their binding with different Immunoglobulin G (IgG) caused changes of
effective refractive index and changes of EOT of the nanopore-structure layer inside the
cavity. As a result, the interference fringes shifted, which could be monitored optically in
real-time. More specifically, after Protein A adhered on the sidewall of nanopores, as
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shown in Figure 6.1, the reflected optical signal from the sensor changed, resulting in the
shift of the interference fringes of the reflected signal. The binding between Protein A
and Porcine IgG are shown in Figure 6.1.

Protein A

Poricne IgG

anopore
Figure 6.1 Closeup of a nanopore region.

The surface of nanostructures inside the FPI was first functionalized with probes
(Protein A). The binding between Protein A and Porcine IgG antibody without tagging
was monitored by the optical transducing signals: interference fringe shift (AX.) upon the
change of the effective refractive index.

6.2

Biodetection Procedures

The assay reagents used in the experiments included Protein A, buffer solution
phosphate buffered saline (PBS), and Porcine IgG. Specifically, Protein A was prepared
in PBS solution at a concentration of 500 ng/mL, which can be diluted accordingly for
different concentrations. The blocking buffer, used to minimize the non-specific binding
was mixed with PBS solution with a ratio of 1:4. Similarly, the Porcine IgG anti-sera
were diluted with PBS with final concentrations of 500 |J.g/mL, 500 ng/mL, 50 ng/mL,
and 5 ng/mL, respectively. The experimental procedures were as follows. First, the PBS
solution was applied into the FPI cavity to rinse the sensor. Thereafter, the Protein A
solution (500 ng/ml) was flowed into the device and allowed to stay inside the FPI cavity
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for 30 mins at room temperature. Sufficient Protein A molecules were allowed to bind to
the Au-coated surface of the nanopore structures and served as capture proteins. The
unbound Protein A was then washed away using PBS solution. The washing routine is
done at least three cycles of 3 mins each. The measurement was taken at each interval
and checked for measurement repeatability. After this step, the solution was flowed into
the device to block the unmodified or unbound sites in the FPI cavity. The solution was
allowed to stay inside FPI cavity for 15 mins at room temperature. After the specified
time, the solution was pumped out and the wash routine performed again to take some
measurements. Similarly, the Porcine IgG solution made with PBS solution was applied
into the device and allowed to settle for 15 to 30 mins in the FPI cavity at room
temperature. The measurements were taken at regular intervals after washing the excess
unbound Porcine IgG using PBS solution.

6.3
6.3.1

Results and Discussions

Protein and IgG Biodetection
The binding between Protein A and Porcine IgG in the nanostructured FPI sensor

was monitored. Measured optical signals from the biosensor are shown in Figure 6.2.
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Figure 6.2 Measured signals for Protein A-IgG binding.

A clear shift in interference fringes was observed during the analyte binding
process. For the same concentration of Protein A, the shifts for varied concentrations of
Porcine IgG were different, which means that there was a change of the effective
refractive index for each case. In other words, the higher the concentration of Porcine IgG,
the more binding between Protein A and Porcine IgG, hence a higher effective refractive
index and larger shift of interference fringes, as shown in Table 6.1.

Table 6.1 Summary of binding measurements.

Material (IgG represents PorcineIgG, P-A represents Protein A)
P-A (0.5 mg/mL)

Average peak shift
relative to P-A (nm)

EOT change
relative to P-A (nm)

P-A + IgG (0.5 mg/mL)

22.9

2072

P-A + IgG (500 ng/mL)

-5.6

1554

P-A + IgG (50 ng/mL)

-13.2

1036

P-A + IgG (5 ng/mL)

-16.9

518
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While the measurement of the shift of interference fringes is a valid way to
analyze and quantify the bioassay process, it is inconvenient to count and average shifts
of hundreds of fringe peaks. In contrast, FT on the measured interference fringe data can
simplify this process [92]. It is well known that the wavelength (A) of the peak maxima in
the interference spectrum for FPI is given by
mX=2nL,

(6-1)

where m is the spectral fringe order, n is the effective refractive index of nanostructure
layer and its contents, L is the geometric gap of the FPI and thickness of nanostructure
layer. 2nL represents EOT and can be obtained from FT of measured spectrum in Figure
6.3. A MATLAB program was written and implemented to perform the FT on the
measured data. As seen with FT on the measured spectrum in Figure 6.3, only a single
peak, whose x-axis position was EOT of the FPI cavity gap and the nanostructure layer,
was presented.
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Figure 6.3 Fourier transform of reflectance spectrum.
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The EOT with immobilized P-A (0.5 mg/mL) was 6214 nm. The EOT changed
after its binding with Porcine IgG (P-IgG) at varied concentrations as summarized in
Table 6.1. Again, for different concentration of P-IgG, the EOT was different. The higher
the concentration of P-IgG, the more binding between P-A and P-IgG occured, hence the
larger the EOT. The DOL of this sensor was evaluated by decreasing the concentration of
the P-IgG. Based on the measured data in Table 6.1, the EOT changed after its binding
with P-IgG at a concentration of 5 ng/mL up to 518 nm, which indicated the DOL of this
biosensor should be much lower than 5 ng/mL.
6.3.2

Detection of Limit
In order to test DOL downward, lower concentrations of Porcine IgG were tested.

Porcine IgG was diluted with PBS with final concentrations of 50 ng/mL, 5 ng/mL, and
10 pg/mL, respectively. The experimental procedures were the same as before.
The measured transducing signals from the biosensor are shown in Figure 6.4. As
can be seen, among different concentrations of IgG, the average shift in interference
fringes at a concentration of 10 pg/mL is the smallest.
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Figure 6.4 Measured signals for DOL test.
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The FT on the measured spectra is shown in Figure 6.5. It shows the changes of
EOT with different concentrations of Porcine IgG. Inset is a table summarizing the AEOT
upon the binding between Protein A and Porcine IgG at different concentrations.
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Figure 6.5 Fourier transform of signals for DOL test.

As expected, the AEOT decreased if the concentration of IgG decreased. The
DOL of this technical platform was, therefore, the concentration of applied IgG where the
AEOT approaches zero or undistinguished by the optical spectrometer. Experiments
found that the AEOT after Protein A binding with IgGat a concentration of 10 pg/mL was
still about 256 nm, which indicated that the DOL of this biosensor should be much lower
than 10 pg/mL for IgG-Protein A binding.
6.3.3

Control Experiments
Control experiments were performed to check if Sea Block bonds with Protein A

or IgG, to confirm that the biodetection is only specific to Protein A and IgG recognition.

76

The procedure for the control experiment to check if Sea Block bonds with
Protein A was carried out as follows. First, two cycles of undiluted solution were pumped
into two devices to ensure the nanostructure sensing surface was fully occupied. The
incubation time was 1 hr, followed by rigorous PBS rinsing. Then, Protein A was applied
and allowed to incubate for 45 mins followed by PBS rinsing. The measurement result is
shown in Figure 6.6. From the measurement result, interference fringes had negligible
shift, indicating Sea Block does not bind with Protein A.
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Figure 6.6 Control experiment for Protein A and Sea Block binding.

The procedure for the control experiment to check if Sea Block bonds with IgG
was carried out as follows. First, two cycles of undiluted solution were pumped into two
devices to ensure the nanostructure sensing surface was fully occupied. The incubation
timewas 1 hr and followed by rigorous PBS rinsing. Then, IgG was applied and allowed
to incubate for 45 mins followed by PBS rinsing. The measurement result is shown in
Figure 6.7.
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From the measurement result, interference fringes had negligible shift, indicating
Sea Block does not bind with IgG. The IgG used in this experiment was rabbit IgG.

6.4

Summary

In summary, a protein-protein (Protein A and Porcine IgG) binding assay has
been used to demonstrate the operation and label-free biomolecular detection capability
of the nanostructured FPI at room temperature. The Au-coated nanostructure layer inside
the FPI cavity offered significantly enhanced optical interference signals due to the LSPR effect and the increased sensing surface area. Immobilization of Protein A on the
nanostructure layer and its binding with IgG inside the FPI cavity were monitored in real
time, resulting in interference fringes shift. FT was performed on the measured
interference spectra to simplify the analysis of the transducing signal. Experimental
results indicated that DOL of the nanostructured FPI biosensor should be lower than 10
pg/mL, which is approximately 55 fM of IgG, for IgG-Protein A binding.

CHAPTER 7
ULTRASENSITIVE DETECTION
OF A CANCER BIOMARKER
7.1

Overview

The detection of cancers at their early stage is critical for survival of patients [97,
98], In the field

of genomics and proteomics, a variety of technologies have been

developed for biomarker discovery and early detection such as various DNA microarrays
[99], DNA sequence methods [100], enzyme-linked immunosorbent assay (ELISA) [101],
two-dimensional polyarylamide gel electrophoresis (2D-PAGE) [102], mass spectrometry
[103], proteomic pattern diagnostics [104], and protein/antibody microarrays [105].
However, most detection schemes suffer from a complicated fluorescent dye labeling
process, bulk instrumentation and low sensitivity, and they are not applicable for trace
detection of biomarkers at the early stage of tumor diseases. For instance, sandwich
ELISA is the gold standard in the detection and quantification of protein/cancer
biomarkers [38], But sandwich assays are inconvenient for achieving large scale
multiplexed measurements [39]. On the other hand, most fluorescent imaging based
techniques are incapable of providing sufficient sensitivity to monitor biomarker affinity
at concentrations of around 10 pM or lower without some forms of signal amplification
[40]. The concentration of many clinically relevant biomarkers residing in biofluids (i. e.,
blood) is usually at picomolar concentrations or lower [39], about 5-7 orders of
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magnitude lower than the most abundant plasma protein. Since there is no universal
ultrasensitive enzymatic amplification method for proteins like polymerase chain reaction
(PCR) for the detection of nucleic acid [39], a diagnostic tool with ultrasensitivity
(picomolar, femtomolar concentration or lower) and high specificity is required.
To this end, micro- and nanotechnologies play a very important role in the
enhancement of the sensitivity and DOL of the biosensing technologies. A variety of
different detection technologies based on micro- and nanotechnologies have been
developed in the past decades for the measurement of the tumor markers at a low
concentration level, showing great promise for potential applications in point-of-care
diagnostics and clinic settings. Among these technologies is the label-free optical
detection technique. Label-free techniques are attractive for biosensing since no
fluorescent dyes are needed to be attached to the biomolecules. As a result, the
experimental cost can be reduced dramatically, and the possible perturbation of the
properties of the biomolecules can be totally avoided.
In this work, a new class of inexpensive polymer-based nanostructured FabryPerot interferometer (FPI) optical microdevices was developed, offering a potentially
powerful label-free technical platform for the detection of protein/cancer biomarkers.
Prior work of the nanostructured FPI microchip focused on the proof-of-concept
demonstrations. Experiments found that the sensitivity of the chip could be down to a
single layer of molecule level, and the DOL of binding between Protein A and Porcine
IgG was lower than 10 pg/mL, which is -55 fM of Porcine IgG. Herein, the detection of
prostate cancer biomarker free prostate-specific antigen (f-PSA) is reported for the first
time using this technical platform.
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7.2
7.2.1

Biodetection Procedures

Immobilization of Detector
mAb on Gold Surface
The immobilization of the detector mAb on the Au-coated surface of the

nanostructured FPI microchip is schematically illustrated in Figure 7.1.
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Figure 7.1 Illustration of SAM formation.

The Au-coated surface was first cleaned with O2 plasma for 15 mins before being
bonded with the PDMS microfluidic layer, followed by a self-assembled monolayer
(SAM) process by incubation in a mixture of 1 mM HSCIOCOOH and HSC80H with
molar ratio of 1:10 in absolute ethanol solution overnight. The SAM then was activated
by incubation in a pH=7.0, 10 mM phosphate buffer solution (PBS) containing 0.5 mM
of EDC/NHS for 2 hrs. The activated SAM was rinsed with the 10 mM PBS and
immediately flowed away by a freshly prepared 10 mM PBS solution containing 10
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Hg/mL of the detector mAb for a 2 or 4 hr incubation. The microchip was then rinsed
with the PBS and followed by a 0.2 M glycine PBS solution for 10 mins in order to
deactivate the remaining active sites at the SAM. Finally, the microchip was ready for
free-PSA (f-PSA) binding detection.
7.2.2

Free PSA Detection
Once the

antibodies (mAbs)

had

been

immobilized on

the

Au-coated

nanostructured surface in the microchip, the detection of f-PSA was ready. The f-PSA
was the unbounded form of the antigen and normally at the level of 10% of total PSA. A
higher amount of f-PSA in a test means a lower chance of cancer. During the experiments,
PBS was used as a running buffer to help minimize the nonspecific adsorption of the fPSA in the tubes and the microfluidic channels.
7.2.3

Control Experiment
Two types of control experiments were designed and carried out to evaluate the

specificity/selectivity of the immunoassay using the nanostructured FPI microdevices.
First, the binding between the detector mAb and BSA at concentrations of 50, 100, 500,
5,000 pg/mL was evaluated. In addition, the binding between the detector mAb and rabbit
IgG at several different concentrations was evaluated.

7.3

Results and Discussions

The average shift of the fringes for the measured transducing signals is obtained
by first obtaining the shift of each fringe peak relative to that of the blank Au-coated
nanostructure surface or after the antibodies (mAbs) have been immobilized on the
nanostructure surface, then averaging the shift of all the peaks. The reference for each
average shift is specified in the context in the following sections.
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The EOT of the nanostructurelayer and the biomolecules immobilized on it was
obtained by performing FT on the measured optical transducing signals, which were
described in detail in the report written by T. Zhang et al.[61 ]. A MATLAB program
based on the fast FT algorithm was developed for this calculation.
7.3.1

Surface Functionalization of
Au-Coated Nanostructures
The surface functionalization of the Au-coated nanostructures was performed

step-by-step, following the protocol as illustrated in Figure 7.1. It is a well-established
method to form a mixed SAM of alkanethiols by the adhesion reaction of the thiol group
on gold surface. The monolayer was well packed and the tethered carboxylic acid was
easily fiinctionalized for biological molecule immobilization. Upon the presence of
EDC/NHS, the carboxylic groups form active O-acylisourea intermediates, and readily
reacted with primary amine groups which exist at the N-terminus of each polypeptide
chain and in the side chain of lysine residues. Because of their positive charge at
physiologic conditions, primary amines are usually outward-facing of proteins; hence,
they were accessible for conjugation without denaturing protein structure. In such a way,
the detector mAbs for f-PSA were covalently attached to the top of the mixed SAMs. The
remaining active O-acylisourea intermediate groups were deactivated by the amino acid
glycine to avoid non-specific biological attachment caused by the intermediates. At this
stage, the mAbswere conjugated to the nanostructured surface and ready for next f-PSA
detection.
Each surface chemical modification step changed the local refractive index and
the effective optical thickness of the nanostructured surface and wasoptically monitored
in real time. The real-time monitoring experiments were carried out on four individual
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nanostructured FPI microchips in the Set I, giving consistent results. As an example,
Figure 7.2 (A) gives a representative step-by-step measurement during the surface
functionalization. The interference fringes (transducing signals) shifted clearly after each
step of addition of organic molecules and biomolecules. It should be noted that all these
measurements were performed at room temperature. The measured interference fringes
for the antibody attachment were obtained after 2 hrs of incubation and three cycles of
rigorous PBS solution rinsing. Compared to the fringes obtained on the nanostructured
FPI microchip with a blank Au-coated nanostructured surface in the range of 550 nm to
850 nm, typical average shifts were 5.13 ± 0.02 nm after the HSCIOCOOH/HSC8OH
was added and reacted with the gold-coated surface. A shift of 9.48 ± 0.02 nm was
observed after EDC/NHS was added and reacted with the surface, and a shift of 13.68 ±
0.02 nm was observed after the antibodies (mAbs) were added and attached to the surface.
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Figure 7.2 Measured signals for antibody attaching process.

The more detailed real-time monitoring of the process of the attachment of
antibodies (mAbs) is given in Figure 7.2 (B). When the mAbs were flowed into the chip,
the optical signals were monitored at different time intervals. It would take some time for
the antibodies to be immobilized and attached to the SAM layer. The measurements
showed a clear shift of the fringes after a lhr incubation at room temperature relative to
that of pre-antibody being applied. The shift further increased after a 2 hr incubation,
indicating that possibly more antibodies were immobilized or attached. Thereafter, three
rigorous rinsings by flowing PBS solution were carried out to remove the unbounded or
loosely bounded antibodies. As expected, the shift of the fringes decreased relative to that
of pre-antibody attached condition, namely the fringes had a red-shift. Experiments found
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that after three cycles of rinsing using PBS solution, no further shift of fringes was
observed, suggesting that all unbounded antibodies had been gotten rid of from the
microchip. After antibodies were attached and immobilized, the measured final average
fringe shift was 4.21 ± 0.02 nm when compared to the fringe of the pre-attachment of
antibodies.
The real-time monitoring of the transducing signals is an important step to verify
that each chemical modification of the sensing surface has actually occurred. This
measurement is particularly useful and effective since there is no need to utilize any
fluorescent dyes to tag organic molecules or biomolecules to visually observe and
confirm the occurrence of each surface modification. In addition, it was also a simple
approach to ensure that the unbounded and loosely bounded molecules had been
completely rinsed away. This is a critical step to guarantee consistent measurements from
each microchip, especially for future reliable and reproducible arrayed microchips for
multiplexed biodetection.
7.3.2

Detection of Cancer Biomarker
Free-PSA
After antibodies (mAbs) were immobilized on the Au-coated nanostructured

surface inside the microchip, the quantitative measurement of f-PSA was carried out.
This part included upper detection range and DOL.
For the upper detection range of the f-PSA, the effect of the amount of antibodies
immobilized on microchips (the same microchips used in experiments as reported in
Figure 7.2) were evaluated. In this set of experiments, the antibody (mAb) concentration
was 10 |ig/mL and the incubation time was 2 hrs. Concentrations of f-PSA flowed onto
the microchip were 100, 500, and 5,000 pg/mL in a PBS solution. The order of the
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experiments was as follows. The f-PSA was flowed

into microchip from lower

concentration to higher concentration. For instance, the f-PSA at a concentration of 100
pg/mL was flowed into the chip first. After a 45 min incubation, PBS solution was
flowed to rinse the microchip three times and measurements were carried out. Then, the
f-PSA at higher concentrations (e. g., 500 and 5,000 pg/mL) were flowed into the chip.
After incubation, a rinsing and measurement routine was carried out again. It was found
that the binding sites had been almost totally occupied after f-PSA with a concentration
of 500 pg/mL was flowed into the chip since interference fringes remained essentially
unchanged even more f-PSA was added. As an example, the measurement in Figure 7.3
showed when the concentration of f-PSA reached 5,000 pg/mL, there was little
observable shift of fringes compared to that of f-PSA at a concentration of 500 pg/mL,
indicating the upper detection range of f-PSA was about 500 pg/mL.
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Figure 7.3 Upper detection range testing.

In order to expand the upper detection range, more antibodies on the microchip
have to be immobilized so that more binding sites are available for f-PSA. However, it
should be also noted that the amount of the antibodies cannot be too excessive; otherwise,
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the antibodies immobilized on the sensing surface are too closely packed and crowded to
allow f-PSA to approach the binding sites efficiently and consequently to be attached to
them. For instance, in one of these experiments, antibodies (mAbs) at a concentration of
100 |ng/mL were immobilized on the sensing surface with a 24 hr incubation, and the fPSA at several concentrations was flowed into the chip for the testing. After rinsing by
the PBS solution, it turned out that essentially no f-PSA had been attached to the
antibodies, resulting in negligible shift in the fringes.
For the DOL, the experiments were carried out on four individual microdevices in
Set II. All the measurements gave consistent results. In this case, the antibodies at
concentration of 10|ug/mL were flowed into the chip with incubation time of 4 hrs. The
concentrations of f-PSA flowed into the microchip were 0, 5, 10, 50, 100 and 500 pg/mL
in a PBS solution. The f-PSA was flowed into microchip from lower concentration to
higher concentration sequentially. Specifically, the f-PSA at a concentration of 0 pg/mL
was flowed into the chip first; after sufficient time (45 mins) for incubation, the PBS
solution was flowed to rinse the microchip three times and measurements were carried
out. Thereafter, the f-PSA at concentration of 5 pg/mL was flowed into the microchip for
the testing. After a 45 min incubation, a rinsing and measurement routine was carried out.
Similarly, the experiments were performed for f-PSA at concentrations of 10, 50, 100,
and 500 pg/mL in sequence, respectively. All these results were obtained by multiple
measurements on four individual microchips, and the average fringe shift for each
concentration was obtained accordingly.
A representative measurement of the transducing signals with the f-PSA flowed
into microchip at concentrations of 0 and 5 pg/mL is shown in Figure 7.4.
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Figure 7.4 Measured signals with different concentrations of f-PSA.

As expected, the interference fringes showed no or a negligible shift with the fPSA at 0 pg/mL, since no f-PSA was actually available to be bounded to the antibodies.
The average shift of the fringes was about 2.19 ± 0.02 nm with the f-PSA at a
concentration of 5 pg/mL in the range of 550 nm to 850 nm, relative to the fringes for the
device with immobilized antibodies. By increasing the concentration of the f- PSA to 10,
50, 100, and 500pg/mL in sequence, the average fringe shift increased as expected since
increasing amount of f-PSA were bounded to the antibodies. The rest of the optical
signals were not overlaid in the plot in order to make the shift clearly readable and visible
for the f-PSA at 5 pg/mL. Experiments have also found that the fringe shift was not
clearly distinguishable when the concentration of the f-PSA was below 5 pg/mL using
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these microchips for the experiments. This undistinguishable shift might be due to the
resolution limit (± 0.02 nm) of the optical spectrometer used in the experiments or the
DOL of these microchips, indicating that the DOL of current microchips for the f-PSA
detection is about 5 pg/mL.
FT has been applied on the measured transducing signals, and the EOT of the
nanostructured layer and the biomolecules immobilized on it was obtained. Using the
EOT after the immobilization of the antibodies as a reference, which is 7,487 ± 2 nm,
AEOT was obtained after the application of f-PSA at different concentrations. In Figure
7.5, AEOT under different concentrations of the f-PSA is summarized.
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Figure 7.5 Changes of EOT with different concentrations of f-PSA.

As expected, the lower the concentration of the f-PSA, the less the f-PSA was
bounded to the antibodies, hence the smaller the AEOT. The EOT for each case was
obtained by averaging several measurements. Again, as can be seen based on the AEOT,
the DOL is about 5 pg/mL or lower, which is -140 fM, for the detection of f-PSA.
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7.3.3

Control Experiment
Finally, control experiments were carried out on microdevices to demonstrate the

specificity and selectivity of the bioassay. In this case, the incubation time of antibodies
at a concentration of 10 ng/mL was 4 hrs. BS A solutions with different concentrations of
50, 100, 500, and 5,000 pg/mL were flowed into the microdevice. For each concentration
of BSA, the incubation time was 60 mins, followed by rigorous PBS solution rinsing
three times. Representative measurements are given in Figure 7.6. No or negligible shifts
in fringes were observed when BSA with four different concentrations was applied to
microchips, confirming the specific recognition between antibodies (mAbs) and f-PSA.
Similarly, experiments were performed to check if antibodies were bounded to rabbit IgG
at concentrations of 50, 100, 500, and 5,000 pg/mL, respectively. No or negligible shifts
in fringes were observed, indicating again that antibodies were only specific to f-PSA.
Overall, these two types of control experiments (BSA and rabbit IgG) suggested excellent
selectivity of the immunoassay.
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Figure 7.6 Controlled experiment using microdevices.
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It should be noted that even though the three sets of devices have somewhat
different transducing signals (i. e., the positions of the fringe peaks were different), for
each set of the devices, a nanostructured FPI device with a blank Au-coated
nanostructured surface from the same set was used as the reference. Hence, consistent
measurement results for the bioassay were obtained for all three types of tests.
As demonstrated, the nanostructured FPI microdevices offered sufficient
sensitivity for the detection of clinically relevant cancer biomarkers, typically in the
range of picomolar concentration levels or lower. Initial experiments have also found that
the sensitivity of a nanostructured FPI device can be further improved by increasing its
finesse by changing the size of and interspacing among nanopores, under further
investigation in our lab. Furthermore, even though this work only reports the detection of
one cancer biomarker, since arrayed devices can be batch-fabricated in an inexpensive
and efficient manner, a disposable platform based on arrayed nanostructured FPI devices
which can be developed for the multiplexed biomolecular detection and analysis may be
seen in the future.

7.4

Summary

In summary, the detection of f-PSA has been demonstrated using nanostructured
FPI microchips successfully. It has been demonstrated that the chemical and biochemical
functionalization of the nanostructured sensing surface can be monitored in real-time.
The upper dynamic detection range can be changed by varying the amount of capture
antibodies immobilized on the sensing surface. Currently, the DOL of the nanostructured
FPI microchip for f-PSA is about 5 pg/mL, which can be further lowered by optimizing
optical properties of the microchip. Experiments have also demonstrated the high
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specificity and selectivity of the immunoassay used in the biosensing, indicating the great
promise for the detection of cancer biomarkers at trace levels in biofluids. Finally, due to
the feasibility of fabricating hundreds of nanostructured FPI microdevices on a single
chip, this technical platform offers great potential for highly multiplexed, label-free
biodetection for the diagnosis of various cancers or diseases in a clinic setting and for
anticancer drug screen and discovery applications.

CHAPTER 8
CONCLUSIONS AND FUTURE WORK
8.1

Conclusions

In this dissertation, an innovative biosensing platform using a nanostructured
Fabry-Perot interferometer was developed, fabricated, and tested. This biosensing
platform was tested for proof-of-concept demonstration and applied for ultrasensitive
detection of the cancer biomarker f-PSA.
For the past few decades, biosensors have seen an expanding market, particularly
in the current climate of growing and aging populations. The need for accurate,
inexpensive, and simple biosensors is going to continually increase. Biosensing can be
achieved by labeled and label-free techniques. Traditional labeled biosensing techniques
require labels such as fluorescent dyes, radioisotopes or epitope tags to be attached to
analytes in order to identify whether there are interactions or not. Therefore, the labeled
technology has shortcomings, such as the limited shelf life of labels, the inherent toxicity
caused by labels which could also modify properties of biomolecules, the need for
specific read-out instruments with intelligent software, and skilled lab personnel. In
contrast to labeled biosensing, label-free techniques are attractive for biosensing since no
labels need to be attached to biomolecules. As a result, the experimental cost can be
reduced dramatically, and the possible perturbation of properties of biomolecules can be
completely avoided. For label-free biosensing techniques, there are three major types of
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label-free biosensors in terms of transducing mechanisms. These transducing mechanisms
include electrical, mechanical, and optical transductions. Due to its high degree of
sensitivity, the capability of multiplexing, and the immunity to the environmental noise,
the optical technique is more attractive for sensing applications than other techniques.
With the advancement of micro- and nanofabrication technologies, many optical
components have been miniaturized. As a result, the field of microoptics and nanooptics
has emerged, triggering extensive research to scale down the optics-based sensing
platforms for past decades. One example is the miniaturization of Fabry-Perot
interferometers. FPIs have been designed and implemented for chemical sensing, gas
sensing,

biosensing, ultrasonic sensing, and optical

modulation. However,

for

biochemical sensing, a conventional FPI has following intrinsic limitations. First, it has a
limited sensing surface area, which means that binding sites available for biomolecules
are limited, resulting in low transducing signals. Second, the optical sensitive range/area
is essentially limited only to the surface of the planar glass plate. Finally, it has a limited
intensity of transducing signals due to optical power losses of the reflected light from the
FPI at the interface of FPI plates.
In order to enhance the optical transducing signal, an innovative biosensing
platform using a nanostructured FPI has been designed. Each FPI consists of a PDMS
plate, an Au-coated nanopore layer and a glass plate. The Au-coated nanopore layer is
anchored on the glass plate, forming a nanopore plasmonic substrate. The PDMS
microfluidic layer can be batch fabricated using an inexpensive, rapid, soft lithography
process. The nanopore structures can be fabricated using a standard two-step anodization
process. The Au-coated nanostructure layer inside the FPI cavity offers significantly
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enhanced optical interference signals due to the L-SPR effect and the increased sensing
surface area.
Measurements have been carried out on the prototype devices to evaluate their
performance using different chemicals. Systematic experiments found that for an Aucoated nanostructured FPI with a nanopore size of 50 nm, it had approximately a twenty
fold improvement in FSR, approximately a two fold improvement in finesse and
approximately a four fold improvement in contrast of optical transducing signals over a
traditional JJFPI even without any device performance optimization. From the
comparison, this novel design offers at least three advantages over a traditional fxFPI
including the increased sensing surface area, the extended penetration depth of the
excitation light, and the tremendous amplification of the optical transducing signal due to
the L-SPR effect. The Raman signal of R6G was also amplified significantly on the Aucoated AAO, which indirectly confirmed that the optical signal enhancement is enabled
by the nanoscale roughness of the Au thin film coated on the nanopore structures due to
the L-SPR effect. The FEA of the intensity distribution for arrayed nanopores also
confirmed great enhancements of optical transducing signals.
The control experiment incubating IgG on gold surface confirmed the small
affinity of IgG to the Au-coated sensing surface. Then, using fluorescent images, shifts of
interference fringes for IgG and BSA interaction were indirectly confirmed.
Using this technical platform, the immobilization of capture proteins (Protein A)
on the nanostructure layer and their binding with IgG were monitored in real time,
resulting in the shift of interference fringes of optical transducing signals, which
demonstrated the operation and label-free biomolecular detection capability of the

nanostructured FPI at room temperature. The Au-coated nanostructure layer inside the
FPI cavity offers significantly enhanced optical interference signals due to the L-SPR
effect and the increased sensing surface area. FT was performed on the measured
interference spectra for simplifying the transducing signal analysis. Experimental results
indicated that DOL of the nanostructured FPI biosensor should be lower than 10 pg/mL
for IgG-Protein A binding, which is -55 fM of IgG. Control experiments were performed
to check if Sea Block binds with Protein A or IgG to confirm that the biodetection is only
specific to Protein A and IgG recognition. Measurements found that for both cases,
interference fringes had a negligible shift, indicating Sea Block does not bind with either
Protein A or IgG.
After the proof-of-concept demonstration, the label-free detection of a cancer
biomarker f-PSA using this nanostructured FPI microchip was performed. Specifically,
the prostate cancer biomarker f-PSA was detected with a mouse anti-human PSA
monoclonal antibody (mAb) as the receptor. Experiments found that the DOL of the
current Au-coated nanostructured FPI microchip for f-PSA was about 5 pg/mL and the
upper detection range for f-PSA could be dynamically changed by varying the amount of
mAb immobilized on the sensing surface. Control experiments also demonstrated that the
immunoassay protocol used in these experiments showed excellent specificity and
selectivity, suggesting the great potential to detect cancer biomarkers at trace levels in
biofluids.
In summary, in this dissertation an innovative biosensing platform has been
designed, fabricated, and tested. This nanostructured FPI microchip-based platform could
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provide an ideal ultrasensitive label-free biodetection tool for point-of-care diagnostic
application and anti-cancer drug screen and discovery.

8.2

Future Work

The ultrasensitive label-free biosensor has been successfully developed and
demonstrated in this dissertation. However, there are a few recommendations for further
improvements.
In this dissertation, nanostructures have arrayed pores with the size of ~50 nm in
diameter. Experiments found that the size of the nanostructure, as well as the spacing
among them, could be tuned by changing operational parameters during the fabrication
process. Therefore, the sensitivity of a nanostructured FPI device may be further
improved by changing the size of and interspacing among nanopores, which is under
further investigation.
Due to the advantage of an inexpensive, rapid, soft lithography fabrication
process, a disposable platform based on arrayed nanostructured FPI devices can be
developed for the multiplexed biomolecular detection and analysis in the future, as shown
in Figure 8.1.
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Figure 8.1 Arrayed nanostructured FPIs on a single chip.

A close up look of a single nanostructured FPI from arrayed nanostructured FPIs
is shown in Figure 8.2.

Figure 8.2 A close up look of a single nanostructured FPI.

The optical signal input and output module were achieved by anexpensive
customized optical fiber probe, shown inFigure 8.3.
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Figure 8.3 Reflected signal measurement setup.

This module consists of a tight bundle of seven optical fibers in a stainless steel
ferrule, as shown inFigure 8.4. The center fiber is to collect the reflected light while the
outer six fibers deliver the illumination light to the FPI chemo/biosensor. The incident
light and reflected transducing light are both on the same side, which makes the structure
complicated and expensive.

Figure 8.4 End surface of customized probe.

In the reflected transducing signal measurement setup,each single biosensorcan be
tested at one time. From the fabrication process, it has been found that the nanostructure
can be made semi-transparent. By using the transmitted optical transducing signal, a
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simple setup can be achieved to separate the incident light and the transducing light as
shown in Figure 8.5. In this transmitted transducing signal measurement setup, only one
light source is needed and multiple biosensors can be tested simultaneously.

Light source

Illumination light

Arrayed chemo/biosensors

Transmitted light
t o s eparate fibers

To speetrom et er

Figure 8.5 Transmitted signal measurement setup.

APPENDIX
COMSOL IMPLEMENTATION
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COMSOL Multiphysics is a powerful FEA software. The graphical user interface
for COMSOL consists of several windows, such as Model Builder, Settings, Graphics,
Messages, Progress, Help, Main Menu, and Main Toolbar. The process flow for
simulation includes model wizard setup, global definition for parameters, geometry,
material, module definition, mesh, study, and results.
The geometry for arrayed nanopores is shown in Figure A-l. The bottom domain
is the alumina domain. The diameter of a nanopore is 50 nm. The spacing among
nanopores is 50 nm. The top domain is the air domain. On top of the air domain is a 5 nm
thick gold layer. L is defined as the pore to pore distance. D is the pore diameter.
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Figure A-l Geometry of arrayed nanopores.
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In order to simulate arrayed nanopores, the periodic boundary condition is set for
a single nanopore cell on both left and right hand side boundaries. The boundary on the
top of the geometry is set as the input source. The geometry of a nanopore with periodic
boundaries is shown in Figure A-2.
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Figure A-2 Geometry of a nanopore with periodic boundaries.

Material properties are assigned to each domain from the material library. The
refractive index for air is 1. The refractive index for alumina is 1.77 at the wavelength of
600 nm. The relative permittivity for gold is -1.74-5.4/ at the wavelength of 600 nm.
Mesh for the gold domain is customized with a maximum element size of 0.5 nm
in order to get an extremely fine mesh. The remaining domain is predefined coarse to
balance the calculation time. The mesh result is shown in Figure A-3. The framed part is
the customized mesh for the gold domain.
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Figure A-3 Mesh for a single nanopore cell.

In order to quantify the enhancement of gold coated nanopores comparing to bare
nanopores, the data from COMSOL are exported to the text file and then imported into
the excel file. After converting the COMSOL data into the excel file, MATLAB is used
to load the data and perform the calculation. All mesh points in the nanopore region are
added together. Thereafter, the sum is divided by the number of points to get an average
value of magnitude enhancement.
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